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Summary
In the last few years there has been an intensive study of 
papillomavirus infections in both humans and animals. To date 
this has resulted in the recognition of 51 distinct types and 
several sub-types of human papillomaviruses (HPV's) and 7 
types of bovine papillomaviruses (BPV's). This interest has 
stemmed from the fact that all these viruses are oncogenic 
and several are potentially carcinogenic in their natural 
hosts, which could possibly provide a valuable insight into 
the molecular mechanism of neoplasia.
Cattle provide us with an excellent animal model system for 
papillomavirus infections in humans, as several 
manifestations are common in the two systems; multiple virus 
types, specificity of lesions, malignant progression of some 
papillomas and the involvement of cofactors.
The studies described in this thesis record a series of 
experiments which help to detail the pathogenesis of BPV's 
and the subsequent immunity by the injection of purified 
virions. Chapter 1 reviews the features of naturally 
occurring HFV and animal papillomavirus infections. It 
details the various isolates, their physical properties, 
their replication cycle, their host range and their potential 
oncogenicity. A detailed description of the main 
papillomavirus infections in both the human and the bovine 
system are given.
Chapter 2 describes the development of the techniques and 
reagents used in the subsequent experiments. The methodology 
provided the purified virus to; 1) experimentally induce BPV 
infections, 2) to localise BPV antigens and 3) to immunise 
against BPV infections.
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In Chapter 3 study of the detailed pathogenesis of 
papillomavirus infections caused by BPV's was possible by 
serially biopsying the experimentally transmitted tumours. 
This permitted the study of the tumour cycle; infection -> 
tumour induction -> tumour regression by BPV-2, 4, 5 & 6.
In the BPV-2 induced infection the first stage of tumour 
development was first reported at 7 weeks after infection. 
This was a fibromatous lesion with no thickening of the 
overlying epithelium and no viral antigen could be detected 
by the peroxidase anti-peroxidase (PAP) technique. However, 
within 7 days there was thickening of the squamous epithelium 
and the establishment of plexiform acanthosis, coupled with 
the presence of a small focus of cells expressing viral 
antigen. The biopsy at 11 weeks after infection revealed a 
fully developed fibropapilloma with an abundance of viral 
antigen in the upper granular layer of the epithelium. By the 
19th week calf 50 had rejected its tumours but calf 49 had 
still a virally active lesion. The process of regression of 
this tumour (calf 49) was slow and it was not until a year 
after the challenge had elapsed before the skin returned to 
its normal state.
Tumour induction by BPV-4 was first recorded 2 weeks after 
infection. These were small, opalescent lesions covering the 
palate. By the 6th week there was a virally active epithelial 
papilloma. The absence of viral antigen was first recorded in 
the biopsy taken 30 weeks after infection. These epithelial 
papillomas remained on the palate, pharynx and oropharynx for 
more than 1 year but no viral antigen could be detected in 
any cells of the biopsies taken after week 30.
The BPV—5 induced lesion was first recognised 26 weeks after 
infection. This biopsy revealed a typical plaque lesion with 
a marked epithelial thickening and cytopathic cells in the 
upper granular layer but with no involvement of the sub-
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epithelial tissue. The latency of this particular infection 
and the development of the tumour was much longer than that 
of BPV-2, 4 and 6. The 'rice grain' tumour, a plaque lesion 
with a protruding papillomatous structure, was first 
identified 37 weeks after infection. By 46 weeks the typical 
BPV-5 induced teat fibropapilloma was well established. 
However, at this stage there was also the emergence of a 
marked mononuclear reaction in the perivascular spaces, which 
by week 52 had started to destroy the basal cells. This 
reaction might well indicate the onset of the rejection 
process.
In the experimentally-induced BPV-6 infection, tumour 
development was first seen 4 weeks after infection but no 
viral antigen could be detected. A virally active lesion was
confirmed at the week 18 biopsy , which is much later than
the infections induced by BPV-2 and 4 but the positive 
antigen reaction remained for approximately for 1 year before 
the regression process started.
Chapter 4 investigates the status of infection and
reinfection among different papillomavirus types. The animals 
selected had all completed the cycles of oncogenesis from 
infection to rejection for BPV-1, 2, 5 & 6 and were
challenged with BPV-4.
All animals developed lesions within 4 weeks of virus 
application. These were small, projectile lesions with no 
demonstrable viral antigen. However, by 8 weeks the lesions 
had developed into typical BPV-4 induced epithelial
papillomas with numerous cells containing viral antigen. The 
lesions were examined at regular intervals over 1 year and 
virus was consistently demonstrated until the 40th week.
These experiments confirmed that all the bovine viruses are 
immunologically different and that immunity to tumour 
induction by BPV-1, 2, 5 and 6 is type-specific.
xiii
Chapter 5 describes the various prophylactic vaccination 
agents used in order to assess their ability to induce 
rejection of a papillomavirus infection. The attempt to show 
protection by immunising with bovine cells transformed in 
vitro failed. However it was demonstrated that cattle could 
be protected against homologous infection and oncogenesis by 
vaccines prepared from virus and tumour extracts. There was 
no obvious advantage in administering virus along with the 
cellular suspension. Prophylactic vaccination using purified 
virions from BPV-2, 4 and 6 was very successful and it also 
showed that this was a type-specific immunity.
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CHAPTER 1
GENERAL INTRODUCTION AND LITERATURE REVIEW
General Introduction and Literature Review
Papillomaviruses have until recently formed one genus of the 
Papovaviridae family. (Melnick, 1962). The papillomaviruses 
(PV's), polyomavirus and the simian vacuolating agent (SV 40) 
each provide the first two letters to form the group name 
PAPOVA. The viruses are named by host specificity and in 
those hosts where more than one papillomavirus exists, by 
type number.
Papillomaviruses are widespread amongst humans and animals 
inducing epithelial or fibroepithelial proliferations of the 
skin or of the mucosa. As all are oncogenic and several are 
potentially carcinogenic in their natural hosts, there is 
considerable interest in the possibility that they will 
provide valuable insights into some of the molecular
mechanisms of neoplasia.
Physical Properties of Papillomaviruses
The papillomaviruses range between 50-55nm in diameter and 
have an external icosahedral protein capsid consisting of 72 
capsomeres, with the width of each being 8nm (Pfister, 1984). 
Within this protective coating there is a double stranded 
circular and supercoiled molecule of DNA. They have a 
genomic length of approximately 8000 base pairs (5xl06
daltons molecular weight); all have the same genetic
organisation (Giri & Danos, 1986); they are not rapidly 
inactivated at high temperatures (eg. 56-65°C for 30 mins); 
they will survive well either frozen or in 50% phosphate 
buffered saline/glycerol.
Papillomaviruses are considered to be of distinct types if 
they show less than 50% homology' by liquid hybridization 
under stringent conditions.
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Papillomavirus Isolates
Papillomaviruses which infect different species are 
serologically distinct but have many properties in common. 
Virus isolates from human, bovine, canine, equine and rabbit 
were studied by density gradient centrifugation followed by 
phosphotungstic acid negative staining, and visualisation in 
the transmission electron microscope (TEM) ; all were found 
to be almost identical in appearance (Crawford & Crawford, 
1963). They were tested serologically by agar gel 
immunodiffusion (AGID) (Le Bouvier et al, 1966) and were 
found to be distinguishable on a host species basis. The
assumption then became common that each host species had one
or occasionally two papillomaviruses ( Rowson & Mahy, 1967). 
The major factor which allowed further discrimination between 
viruses within a species was the development of restriction 
enzymes, molecular cloning and genome mapping techniques. The 
first maps of the human virus were produced by Gissman et al,
1976 and Orth et al, 1977 and of the bovine by Lancaster,
1979; Jarrett et al, 1980 and Campo et al, 1981.
There has been an exponential increase in the number of new 
human viruses isolated since then and this has resulted in 
the recognition to date of 51 distinct types and several 
sub-types. Seven bovine virus types have been identified.
Replication
It is now accepted that any one species may have a number of 
different and often partly related papillomaviruses causing 
various lesions in a variety of animals (cattle, horses, 
rabbits, dogs, sheep, goats, deer, hamsters and monkeys). 
Usually the tumours show a limited growth span and regress 
spontaneously.
Papillomavirus virion replication is largely confined to
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sites producing keratin as the viral cycle is linked to the 
differentiation of epithelial cells (Orth et al, 1971). The 
virus is assembled in the granular and corneal layers of the 
skin but not in the keratinocyte or basal layers although 
viral genomes can be detected there by the use of in situ 
hybridization techniques. However some tumours are virus 
induced without virion replication and structural antigen 
production, notably the mesenchymal tumours induced by bovine 
viruses eg. these tumours contain non-integrated
papillomavirus genomes (Howley et al, 1980 and Moar et al, 
1981).
In Vivo ; Host Range and Oncogenicity
Papillomaviruses display a wide range of oncogenicity in 
vivo. Some viruses produce benign, epithelial, hyperplastic 
lesions restricted to their host species (Rowson and Mahy, 
1967), while others are oncogenic in a number of animal 
species (Campo, et al, 1980; Kidd & Rous, 1940; zur Hausen,
1976). In general these latter members produce tumours 
restricted to epithelial and mesenchymal tissues and to their 
equivalents in the central nervous system.
The progression of papillomas to carcinomas is stimulated by 
genetic and/or environmental factors. The best examples of 
these are: the cottontail rabbit/domestic rabbit, where the
genetic make up of the host is an important factor 
determining the extent and rate of malignant conversion 
(Kreider, 1980): the progression to carcinomas of the
Epidermodysplasia verruciformis (EV) lesions in areas exposed 
to sunlight in individuals with impaired cell-mediated 
immunity (Orth et al, 1980); and the transition of papillomas 
to carcinomas in the upper alimentary tract of cattle feeding 
on the bracken fern (Jarrett et al, 1978). Oriel in 1971 
recognised the malignant transformation of anogenital warts 
whereas recently serious study has been made of the
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association between cervical cancer and cervical intra­
epithelial neoplasia (CIN) and papillomavirus infection (zur 
Hausen, 1977; Morin et al, 1981; Crum et al, 1984).
Recently there has been renewed interest in some of the human 
papillomaviruses (HPV's) as carcinogenic agents in humans. 
Examples of tumours in which HPV's have been isolated include 
common warts (Green et al, 1981), genital warts (de Villiers 
et al, 1981; Gissman et al, 1982), cervical dysplasias and 
carcinomas (zur Hausen, 1976; Meisels et al, 1982), various 
non-verrucoid skin tumours (Kawashima et al, 1986; Spradbrow 
et al, 1983; Scheurlen et al, 1986; Gassenmaier et al, 
1986), conjuctival neoplasia (McDonnell et al, 1986) and 
oesophageal carcinoma (Kulski et al, 1986).
Human Infections
To date 51 distinct HPV's and several sub-types have been 
identified. Most of the papillomavirus DNA's under 
investigation were molecularly cloned from biopsy material 
and not from purified virions. They are regarded as viral 
DNAs if they satisfy the following criteria (1) they are in 
the size range of seven to eight kilobases (kb); (2) they
persist in the tumour as extrachromosomal, circularly closed 
DNA; (3) they have partial sequence homology with other 
papillomaviruses; and (4) have a genomic organisation similar 
to other papillomaviruses. A virus isolate is considered 
novel if it shows less than 50% DNA sequence homology with 
other viral types under stringent conditions, whereas a sub- 
type is defined as having greater than 50% homology with a 
known virus but a different restriction endonuclease map 
(Coggins and zur Hausen, 1979). The human papillomaviruses 
have been divided into seven major groups (A-G) based on 
their molecular relationship ie. they share at least 1% DNA 
sequence homology and on their clinical and pathological 
characteristics (Pfister, 1984).
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Group A has HFV-1 type virus which is associated with deep 
plantar warts, verruca plantaris.
Group B includes HPV-2, 3 & 10 which are found in the common 
and flat warts; verruca vulgaris, verruca plana and 
epidermodysplasia verruciformis (EV).
Group C has HFV-4 which is found in verruca vulgaris 
lesions.
Group D includes HPV-5, 8, 9, 12, 14, 15 & 17 which are
associated with pityriasis-like lesions of EV and are also 
found in squamous carcinomas.
Group E contains HPV-6,11 & 13 which are the venereally 
transmitted agents of genital warts of the condyloma 
accuminata type. HFV 11 is involved in laryngeal 
papillomatosis.
Group F contains HPV-7 associated with butchers' warts.
Group G contains HPV-16 and 18 implicated in cervical 
intraepithelial neoplasia (CIN), genital cancer and Bowen's 
disease.
Common Warts
Verruca plantaris and verruca vulgaris are the commonest 
virally induced tumours found in the general population, 
where approximately 30% of individuals have antibodies to the 
viruses involved. It has been found that HPV's 1 and 2 are 
involved in these lesions and can be detected as episomes 
within the tumour cells. These tumours mainly occur in 
school children and during early adolescence ; they are 
totally benign in nature with the exception of two cases
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where there was a malignant transition into squamous 
carcinoma (Grussendorf and Gahlen, 1975; Shelley and Wood, 
1981). With so very few reports of such cases it would lend 
credence to the theory that papilloma virus types found in 
the common warts do not induce malignant growth in epidermal 
cells. Carcinomas arising after such infections occur only 
after long latency periods from sites without earlier wart 
development. The incidence of verrucae vulgaris is increased 
in patients with immunodeficiency eg. those who have had 
renal transplants and more than one year of immunosuppression 
(Spencer and Andersen, 1970); these may progress to squamous 
carcinoma.
Genital Lesions
For many years it had been suggested that there was a link
between promiscuous sexual activity and the development of
cervical cancer. Kessler's epidemiological study in 1983 
showed that cervical neoplasia is a sexually transmitted 
disease. Until relatively recently, herpes simplex type II 
virus was thought to be the aetiological agent involved in 
cervical cancer. This was based on data which observed a 
high correlation between the incidence of cervical cancer and 
the elevated serum antibody titre to the herpes virus (Rawls 
et al, 1969). However in 1976 zur Hausen, using molecular 
hybridization techniques, suggested that specific types of 
papillomaviruses might be the aetiological agent involved.
i) Condyloma Acuminata
Condyloma acuminata, the anogenital wart of man, is
venereally transmitted (Teokharov, 1962; Marino, 
1964; Oriel 1971 & 1971b; Waugh, 1972; zur Hausen 
et al, 1975) and is prevalent in populations of high 
sexual promiscuity (Underwood et al, 1971; Waugh,
1972). Condylomas are generally benign but invasive
conversions have been regularly reported (Siegal,
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1962; zur Hausen, 1977; Morin et al, 1981; Crum 
et al, 1984) . HPV-6 and 11 are the predominant viral 
types involved and episomal DNA can be detected in 
90% of the lesions (Gissman et al, 1983; zur Hausen, 
1985). The viruses have also been identified in low 
grade cervical dysplasias (CIN) which tend to regress 
rather than progress to malignancy (Crum et al, 1984) . 
HPV 16 and 18 have also been identified in condylomas 
but to a lesser extent than in high grade cervical 
dysplasias (CIN 11 and 111) and carcinomas.
ii) Vulvar, Penile and Vaginal Neoplasia
HPV 16 and 18 have been associated with a range of 
epithelial atypias, with penile warts, with squamous 
carcinoma of the penis (Durst et al, 1983), with
Bowenoid papulosis (BP) of the vulva and penis (Wade 
et al, 1979; Steffen, 1982; Ikenberg, 1983;
Guillet et al, 1984; Gross et al, 1985), with vulvar 
and vaginal intraepithelial neoplasia, and with 
squamous carcinomas (Gissman and Schwarz, 1986). These 
infections have become a serious clinical problem in 
sexually promiscuous young women (Oriel, 1981;
Syrjanen, 1984; Okagaki, 1984). The correlation of 
several different manifestations of genital carcinomas 
with papillomaviruses is now very convincing 
(Syrjanen, 1986).
iii) Cervical Neoplasia
Epidemiological evidence indicates that cervical 
carcinoma and other high-grade dysplastic lesions of
the female genital tract are sexually transmitted 
diseases. Cervical cancer has not been reported in nuns
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and other virgins (Rigoni-Stem, 1842) whereas the 
sexual partners of men whose first wives had cervical 
cancer are at a much greater risk themselves (Gross et 
al, 1985b; Kessler, 1986). Many of the risk factors 
for these cancers are indirectly related to certain 
lifestyles but are indicative of a venereal aetiology. 
These are the onset of sexual relations at an early 
age, sexual promiscuity, use of oral contraceptives, 
lower socioeconomic status and multiple • kinds and 
episodes of infections (Brinton, 1986; Doll, 1986). 
Cervical dysplasias and carcinomas are more frequent 
among smokers than non-smokers (Vesey, 1986). The 
microorganisms which have been implicated as the 
causative or contributory agents include Treponema 
pallidum (syphillis), Neisseria gonorrhoeal, Chlamydia 
trachomatis, Trichomonas vaginalis, herpes simplex and 
cytomegalovirus, but proof of carcinogenesis has been 
lacking in every case.
Cervical intraepithelial neoplasia (CIN) is histologically 
diagnosed in the following stages: 1) CIN grade I: mild
dysplasia; 2) CIN grade II: moderate dysplasia; 3) CIN 
grade III: severe dysplasia and carcinoma in situ. These may 
be followed by invasive carcinoma. The current concept of 
squamous carcinoma of the cervix is that it is a multi-stage 
disease developing over a 10 to 15 year period. It is 
recognised as a three stage disease by the pathologists: a
preinvasive, a microinvasive and an invasive stage.
HPV infection of the uterine cervix produces flat acetowhite 
lesions commonly described as atypical condylomas, which come 
into the category of CIN (Meisels et al, 1977) . These 
condylomatous lesions may be classed as being (a) of a mild 
cytological atypia characterised by a high degree of 
koilocytosis with diploid or polyploid chromosomes. These 
are likely to regress and have been associated with HPV-6, 10
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or 11; (b) a marked cytological atypia which has a low
degree of koilocytosis containing aneuploid chromosomes. 
These are more likely to progress through CIN to squamous 
carcinomas and are associated with HFV 16 and 18 (Crum et al, 
1984; McCance et al, 1985). Cervical cancer has an 
extremely high association with the presence of HPV 16 or 18, 
the figure ranging from between 60-90% of cases in various 
studies (Durst et al, 1983; McCance et al, 1985b; 
Boschart et al, 1984). This strongly suggests the 
involvement of these viruses in the aetiology of cervical 
cancer.
It has also recently been demonstrated, by Kreider and his 
colleagues (1985), that HPV-II infections induce changes 
characteristic of koilocytotic dysplasia upon infection of 
human cervical tissue heterografted beneath the renal capsule 
of nude mice. Viral production was observed, therefore 
Koch's postulates were fulfilled for HPV-II being the 
causative agent of this kind of lesion. Moreover, Kreider 
et al, (1986) reported that HPV-II particles are produced in 
considerable amounts in such heterotransplants which offers 
the possibility of producing viral particles of different 
HPV's even when they are replicating very poorly under 
natural conditions. It is anticipated that this technique 
will establish the causative role of HPV's in CIN and 
therefore point to a aetiological role of these agents in a 
clearly pre-malignant disease. Since HPV 16 and 18 have 
been directly isolated from cervical carcinoma biopsies, it 
is an important question to clarify their role in this type 
of cancer.
Interestingly, in condylomatous and CIN lesions of all 
grades, the HPV-DNA is free and unintegrated, whereas in the 
majority of malignant tissues HPV types 16 and 18, it is 
integrated into the host cell genome (Durst et al, 1983; 
McCance et al, 1985). Although Tooze (1980) wrongly stated
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that integration of animal DNA tumour viruses is a pre­
requisite for cell transformation in vitro and tumour 
production in vivo, it still has to be demonstrated that 
integration of HFV-DNA accounts for the malignant 
transformation of cervical cells.
Laryngeal Papillomas and Carcinomas
Laryngeal papillomas are rapidly growing, benign epithelial 
neoplasms caused primarily by HPV's 6 and 11 (Gissman et al, 
1982, Mounts et al, 1982). They are usually located on the 
true vocal cords and epiglotis, but sometimes involve all of 
the larynx, the trachea, bronchial tubes and even the lungs. 
These papillomas are generally subdivided into "juvenile1 and 
"adult" types due to the bimodal age distribution, with one 
peak between 2-5 years old and the second between 40-60 years 
old (Quick, et al, 1978). Juvenile papillomas are rare 
tumours in Europe and the United States, whereas the 
prevalence is much higher in South American Indians where 
there is a 33-85% incidence rate (Soneira & Fonesca, 1964). 
Although the incidence is relatively low it has however a 
high degree of morbidity and mortality. The juvenile 
papillomas are often multiple and recur but they do tend to 
regress spontaneously at puberty. This remission can be 
temporary or can last the lifetime of the patient. There is 
little doubt that these papillomas are induced by a 
papillomavirus ; typical viral particles have been 
demonstrated by electronmicroscopy (Boyle et al, 1971 and 
1973). These juvenile papillomas are almost certainly caused 
by infection during birth, since the mothers of these 
children frequently have genital warts (Duff, 1971; Boyle et 
al, 1973). Further evidence for the association of laryngeal 
and anogenital papillomas comes from a comparison of their 
viral DNA's (zur Hausen et al, 1974; Gissman et al, 1977 
and 1983). The studies of Steinberg's group (1983) have 
suggested that the virus is present not only in the
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papillomas but in apparently normal tissues taken from both 
patients with active disease and from patients in spontaneous 
remission.
The adult papilloma syndrome appears to present itself as a 
pre-malignant disease. The tumours occur twice as frequently 
in males as in females. In longitudinal studies the 
conversion to malignancy is more than 20% (Kleinasser,
1973) . How the infection is transmitted in these cases is 
unknown but it is possible that infection is acquired during 
the birth process and remains latent or subclinical until 
the onset of symptoms decades later (Mounts & Shah, 1984).
In the past the treatment of choice was radiotherapy. However 
it was observed that after an incubation period ranging from 
5-40 years, many papillomas became malignant, suggesting a 
synergistic relationship between x-rays and viral infection 
(zur Hausen, 1977). Florid oral papillomatosis may also 
occasionally convert into squamous cell carcinomas (Samitz et 
al, 1967) without the intervention of x-rays or other 
treatments.
Whilst episomal forms of HFV-11 DNA can be identified and 
isolated from benign papillomas, viral DNA had not until 
recently been identified in laryngeal carcinomas. The 
development of increasingly sensitive probes has enabled the 
discovery of integrated and rearranged viral genomes within 
malignant cells (Scheurlen et al, 1986 & 1986b).
Epidermodysplasia Verruciformis (E.V.)
E.V. is a dermatosis where verruca plana papules appear 
usually by puberty and disseminate to a great extent in early 
adult life (Jablonska & McLewsky, 1957). Although perhaps
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one of the rarest HFV-associated conditions, it is amongst 
the most well documented and widely studied. It is seen as 
two distinct types, flat warts and pityriasis versicolour- 
like lesions. As the affected individuals get older (20-40 
years) around 30% develop malignant skin carcinomas of the 
Bowenoid or squamous type (Orth et al, 1979). Squamous cell 
carcinomas develop first at light-exposed sites of Caucasians 
(Schellender & Fritsch, 1970; Ruiter & Van Mullem, 1970 and 
1970b; Jablonska et al, 1972) and it has therefore been 
suggested that sunlight and in particular U.V. radiation 
might play a role in the development of malignancy. This 
theory is further supported by the observation that EV is 
much rarer and has a much better prognosis with respect to 
the development of malignancy in black races (Jacyk & 
Subbuswany, 1979). It has also been noted that 27% of 
Caucasian patients have malignant conversion of papillomas 
after more than 5 years of existing verrucosis generalisata 
(Touraine, 1961).
Genetic factors too are believed to play a role as there is 
frequently a family history of EV and an autosomal recessive 
gene may be involved (Lutzner, 1978) . Defects in cell- 
mediated immunity, which occur in many of these patients, 
have also been implicated in the aetiology of this condition 
(Glinski et al, 1976; Prawer et al, 1977), although the 
presence of an abnormal immune response may not correlate 
with the development of malignancy as patients with 
carcinomas have been found to have apparently normal cell 
mediated immunity (Orth et al, 1980).
Although papillomaviruses have been suspected of being 
implicated in squamous cell cancer of the skin and mucosa of 
man for some time (Aaronson & Lutzner, 1967; zur Hausen,
1977) the first demonstration of papillomavirus in such 
cancers was in 1980 when Orth's group detected HFV-5 DNA in 
patients with E.V. To date, over 25 different types of
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papillomaviruses have been isolated from E.V. patients; 
however only specific types are associated with the 
development of malignancy. The flat warts are generally 
associated with HPV 3 and 10 which tend not to undergo 
malignant transformation, whereas HPV 5 and 8 are mainly 
isolated from the pityriasis versicolour-like lesions and 
they frequently become carcinomatous (Orth et al, 1979). 
Other HPV's were also found to be potentially oncogenic: HPV
14, 17 and 20 (Kremsdorf et al, 1984; Tsumari et al, 1983; 
Gassenmaier et al, 1984). Papillomavirus-like particles 
can be identified in benign lesions by microscopy but not in 
malignant lesions (Aaronson & Lutzner, 1967); only HPV DNA 
in genomic form is found in the latter (Orth et al, 1980). 
An E. V. patient may have benign lesions infected by multiple 
HPV's of the specific types: HPV - 3, 5, 8 , 9, 10, 12, 14,
15, 17, 19, 20, 21, 22, 23 and 24 (Kremsdorf et al, 1982 and
1983; Lutzner et al, 1984; Orth et al, 1980; Pfister et al, 
1981 and 1983).
Miscellaneous
A) Butcher's Warts :
Butcher's warts, which involve HPV-7, are found almost 
exclusively on the hands and forearms of veterinary 
surgeons, meat-handiers and butchers although there is 
no evidence to suggest that HPV-7 is related to any of 
the bovine papillomaviruses. Jablonska et al in 1982 
found a proportion of butchers (25 of 83) to be
infected with two and sometimes three HPV types which
generally localised to the palmar and dorsal sites of
the hands. They are not malignant and regress 
spontaneously (Orth et al, 1981).
B) Focal Epithelial Hyperplasia of Heck : This is an 
extremely rare condition in Caucasian races, which was
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first identified in North American Indian tribes. It 
affects the buccal mucosa causing focal hyperplasia and 
occurs mainly in children and young adults with 
frequent manifestations in the same family, which may 
indicate that adults have an acquired immunity against 
it. They may persist for several years but do not 
become malignant and tend to regress spontaneously. 
This lesion has HPV-13 involvement.
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Animal Infections
The rabbit papilloma virus is one of the best documented of 
the papilloma virus group (Shope, 1933). This virus induces 
skin warts in cottontail rabbits under natural conditions and 
in domestic rabbits under experimental conditions. These may 
develop into carcinomas in up to 25% of the cottontail 
rabbits and in up to 75% of the domestic rabbits (Rous & 
Beard, 1935; Syverton, 1952). Only two leporine viruses 
have as yet been identified.
In the model system, papillomas may be induced by intradermal 
infection of the virus. Malignant progression is enhanced 
by the application of tar to the papillomas (Rous & Kidd, 
1938). Virus on its own can produce papillomatous lesions, 
whilst tar cannot, but neither the virus or the tar alone 
can initiate malignancy. However, when applied together to 
the skin, they induce aggressive malignant neoplasms.
Besides the human and rabbit systems, papillomaviruses have 
been found in cattle (Olson & Cook, 1951), which will be 
dealt with in greater detail in this thesis; goats (Davis & 
Kemper, 1936), horses (Montes & Vaughan, 1975), dogs 
(Cheville & Olson, 1964), monkeys (Koller & Olson, 1972), 
hamsters (Graffi et al, 1969) , sheep (Gibbs et al, 1975), 
chaffinches (Osterhaus et al, 1977), and also in mice (Muller 
& Gissman, 1978).
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Bovine Papillomavirus Infections — Range and Tissue
Specificity
Bovine papillomaviruses (BPV's) have been extracted from a 
variety of lesions occurring in different anatomical sites in 
cattle. BFV was found to be the causative agent of 
cutaneous fibropapillomas (Creech, 1929); genital 
fibropapilloma (McEntee, 1952); and it may be associated 
with bladder tumours of cattle (Olson et al, 1965).
"Atypical" skin papillomas have been shown to contain BPV 
(Barthold et al, 1974) . BPV's have been extracted and 
characterised from alimentary papillomas, alimentary 
fibropapillomas, penile papillomas, 3 types of teat
papillomas and fibropapillomas (Jarrett, 1978; Campo et al, 
1981; Jarrett et al, 1984). Experimentally BPV induces 
meningiomas in calves (Gordon & Olson, 1968); "sarcoid" 
tumours in the horse (Olson & Cook, 1951; Lancaster et al,
1977) ; fibroblastic and liposarcomatous tumours in the
hamster (Boiron, et al, 1964; Cheville, 1966; Robl et al,
1972; Robl & Olson, 1968; Moar et al, 1986) and fibromatous 
tumours in C3H/IB mice (Boiron et al, 1964).
Papillomavirus In Vitro
Bovine papillomaviruses have been shown to transform murine 
cells in tissue culture (Black et al, 1963; Thomas et al, 
1964; Campo et al, 1983); bovine kidney and foetal bovine 
conjunctiva (DBC) cell lines (Moar et al, 1981b); secondary 
cultures of foetal bovine heart (Black et al, 1963); foetal 
bovine skin cells and secondary fibroblastic cultures of 
various strains of foetal mouse (Thomas et al, 1963 and
1964). BPV-1 which causes fibropapillomas of the teat and
fibropapillomas of the penis can transform fibroblasts in 
vitro and have been found to contain viral DNA (Campo et al, 
1980). Foetal equine fibroblasts are also transformed with
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BPV-1 (Wood & Spradbrow, 1985). BPV-2 which represents the 
virus isolated from the classical cutaneous fibropapilloma 
found on the neck and shoulders of cattle has been shown to 
transform bovine conjunctiva and palatine cultures (Moar et 
al, 1981).
The Immunology of Bovine Papillomaviruses
Virus antigen was first detected in fibropapillomas using 
immunofluorescence (Smithies & Olson, 1961). Immunodiffusion 
was also employed in an attempt to estimate the quantities of 
bovine papillomaviruses and anti-viral antibodies during the 
regression of fibropapillomas and the relationship of the 
latter to anti-viral antibody in the serum. It was however 
an insensitive technique (Koller et al, 1974). No 
correlation was found and the fibropapillomas continued to 
grow in the face of anti-virion antibody (Barthold & Olson, 
1974b). The fibroma cells of BPV-induced fibropapillomas 
lacked viral antigens detectable by their current 
immunocytochemistry and electron microscopy (Smithies & 
Olson, 1961; Robl & Olson, 1968), but it was claimed that 
they possessed a surface antigen detectable by indirect 
immunofluorescence on live, unfixed, BPV-induced fibroma 
cells grown in vivo and in vitro (Barthold & Olson, 
1974b). Serially sampled fibropapillomas show considerable 
histopathological evidence of a major role played by cell- 
mediated immunity (CMI) in the regression of at least the 
fibroma component of bovine fibropapillomas (Barthold & 
Olson, 1974b). Humoral responses (Segre et al, 1955; Lee 
& Olson 1969 and 1969b; Barthold et al, 1976) have also been 
documented but again the antibodies present in the sera of 
these animals do not appear to be related to growth or 
regression of papillomas. A role for CMI has been supported 
by the observations that persistent papillomatosis in cattle 
is associated with a CMI deficiency syndrome (Duncan et al, 
1975). Most ofthe data now forth-coming on humoral responses
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to BPV's have been obtained by measuring antibody responses 
to cutaneous and alimentary papillomas using a variety of 
techniques e.g. immunocytochemistry (PAP technique) , 
complement fixation, ELISA, serum neutralisation and 
immunoblot assay (Western), the results of which will be 
discussed later.
Physiochemical Characteristics of Bovine Papillomaviruses
Three phys iochemical aspects are relatively important; 1) the 
ability to agglutinate red blood cells; 2 ) virus particle 
diameter and 3) virus theremostability. The above aspects 
were important formerly due to the fact that these 
characteristics were used to differentiate between individual 
papovavirus members. However today the molecular weight of 
the viral DNA is used to type the different papillomaviruses. 
Again until recently haemagglutination represented one of the 
principal methods of quantitating virus and anti-viral 
antibodies. BPV has been shown to agglutinate mouse RBC's at 
4°C between pH6 . 8 and pH 8.4. BPV is eluted at 37°C. RBC 
receptors are resistant to receptor destroying enzyme (RDE) 
and influenza neuraminidase. Haemagglutination is associated 
with both full and empty viral particles (Favre et al, 
1974). We have shown that while BFV-1 has haemagglutinating 
receptors, BPV-4 has not. However haemagglutination is not a 
sensitive assay technique.
In searching through the relevant literature it is apparent 
that there is a wide range of estimates of virus particle 
diameter using both negative staining technique and thin 
sections by electron microscopy. There are inherent 
difficulties in interpreting these preparations as negatively 
stained specimens may contain flattened virions; in the thin 
section technique, diameter estimates may be low due to the 
shrinkage caused by dehydration and embedding (Gross L, 
1970). Estimates therefore may vary considerably due to
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preparatory methods.
On the thermostability aspect of the virus it has been found 
that most members are able to survive at least 30 minutes at 
60°C. It is of interest that the DNA can withstand high 
temperatures for long periods largely because of its unique, 
closed circular form. Crawford et al, 1964, noted that at 
high temperatures the DNA disassociates into single strands 
but reassociates on cooling. The increased thermostability of 
viral DNA over whole virus may be due to the earlier 
denaturing of the viral capsid protein.
No in vitro system of virus replication has yet been 
developed and virus purification depends entirely on the 
isolation from tumours (Gissman & zur Hausen 1976; Gissman 
et al, 1977; Orth, et al, 1977; Jarrett et al, 1980).
The question of whether BPV can infect man has still to be 
resolved. Papillomaviruses found in the hand warts of 
butchers were studied by molecular hybridization, restriction 
enzyme analysis and immunofluorescence (Jablonska et al, 
1980). HPV-1, 2, 3 and 4 were detected ; one papillomavirus 
now called HPV-7 whose DNA did not anneal with any of the 
RNA's complementary to either HPV-1 to 5 or to BFV-1 was 
found. The question as to whether this virus is of human or 
animal origin is still open.
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Bovine Papillomavirus Infections
In the last few years an intensive study of BPV's has been 
undertaken by Professor W F H Jarrett and his group. To date 
7 BPV's have been recognised and 6 characterised. Each is 
associated with specific lesions (Campo et al, 1981; Jarrett 
et al, 1984 and 1985). The viruses fall into two subgroups : 
subgroup A causing fibropapillomas, and subgroup B causing 
true epithelial papillomas (Table 1) .
Table 1
Lesion Specificity of Bovine Papillomaviruses
Virus Lesion
Group A BPV-1 1) Penile fibropapilloma
2) Teat frond fibropapilloma
3) Adjacent skin fibropapilloma
Group A BPV-2 1) Classical skin fibropapilloma
2) Alimentary fibropapilloma
Group A BFV-5 Teat "Rice Grain" fibropapilloma
Group B BPV-3 Skin papilloma
Group B BPV-4 Alimentary (true) papilloma
Group B BFV- 6 Teat (true) frond papilloma
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The viruses in Group A transform both fibroblasts and 
epithelial cells whereas the viruses in Group B transform 
only keratinocytes. The subgroups can also be clearly 
distinguished immunologically and by differences in genome 
size and organisation. In both the fibropapilloma and the 
squamous papilloma, the viral DNA is present in cells in a 
non-integrated episomal form. Viral replication takes place 
only in keratinocytes which are undergoing terminal 
differentiation. A brief description of the differentiation 
of the epithelium is necessary to understand the natural 
progression of viral infection. The epidermis generally 
matures over a 10-14 day interval by progressive vertical 
differentiation of basal cells. As they mature they form a 
prickle cell layer which in turn begins a succession of 
changes in keratin gene expression (Franke et al, 1986) . 
Superficial to the prickle cell layer comes the granular 
layer of two to four rows of polygonal cells which lie 
parallel to the skin surface. At this level the death of 
the epidermal cells begins. The dead or superficial cells 
are anucleate and contain a precursor of keratin derived from 
keratohyalin. Finally, on the surface, the keratin- 
containing cells become devoid of structure and constantly 
desquamate ; they are replaced from beneath. Internal 
mucosal squamous epithelium expresses a different set of 
keratins as it differentiates ; in the human it does not 
develop but in the bovine there is cornification.
Infection with papillomavirus apparently requires direct 
access to one or more basal epithelial cells (Jarrett, 
1985) . The virus can be demonstrated replicating in the 
nuclei of cells in the stratum spinosum and in the stratum 
granulosum (Almeida et al, 1962). After partial 
disintegration of the cell structures, aggregates of virus 
are readily demonstrated in the stratum granulosum and 
corneum by immunocytochemical techniques (Orth, et al, 1971). 
In other words, epidermal cells are non-permissive for
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papillomavirus replication in the beginning of their 
differentiation process but become more permissive with 
increasing differentiation. The specific factors allowing the 
development of papillomavirus replication are still unknown.
BFV-1 Tumours
Jarrett et al, (1980) found that (1) BFV-1 was primarily 
associated with paragenital lesions because 40% of animals 
had such tumours on their teats and (2) BFV-2 was associated 
with cutaneous fibropapillomas in cattle reared in the United 
Kingdom; Lancaster and Olson, (1978) did a small survey in 
the USA and found both BFV-1 and BFV-2 in naturally occurring 
fibropapillomas of the head, neck and flank. Pfister, 1980 
obtained similar results but he also found both BFV-1 and 2 
in fibropapillomas of the udder.
A comprehensive review of bovine papillomavirus infections 
has been given by Jarrett (1985) .
The basic morphology of cutaneous fibropapillomas induced by 
BPV-1 and 2 are identical. Experimental infections with
purified virus were carried out and the development of the 
tumours observed by serial biopsies (Jarrett 1985). In these 
situations it was found that the time between infection and
the appearance of the tumour depended on the concentration
and infectivity of the virus and the depth of skin 
scarification made before applying the virus. In the first 
2 to 3 weeks after infection, the scarification wound healed 
but thereafter there was obvious proliferation of 
fibroblasts which continued for a further 4 weeks. The
cells, many of which were undergoing mitosis, had large 
hyperchromatic nuclei and abundant cytoplasm. At this stage 
there was no thickening of the granular layer and there was 
no evidence of either proliferation or cytopathic changes.
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This stage could persist for several months in which the 
fibroma may range from 3 to 20 cm. The study of serial 
biopsies showed that transformation was taking place in the 
subepithelial cells and extended by infiltration of the 
tumour among the hair follicles and skin adnexae. The latter 
disappeared and the tumour developed as a solid bulbous form. 
Histologically this was seen as a benign fibroma. As the 
tumour developed the fibroblasts under the basal layer of the 
epithelium became very large and contained multiple copies of 
the viral genome when examined by in situ hybridization or 
DNA extraction. However in our studies, even after numerous 
attempts by electron microscopy, virus isolation and 
immunocytochemistry, we failed to detect either virus antigen 
or virions. In the growth phase of the fibromatous 
component of the tumour the proliferating epithelium appeared 
as a thickened crust on the surface of the tumour which in 
places penetrated deeply into the fibromatous tissue. This 
downward growing network of epithelium is termed plexiform 
acanthosis by Professor W F H Jarrett. The final stages of 
development consisted of a thickened granular cell layer, 
enlarged keratohyalin granules, hydropic degenerated cell 
cytoplasm and marginated nuclear chromatins. The latter is 
associated with the replication of virus particles and these 
virus containing nuclei move upwards into the hyperkeratotic 
keratin layer. At this point papillomatosis developed with 
projecting processes which consisted of proliferating 
keratinocytes, granular and keratin layers with a central 
core of blood vessels and connective tissue. 
Fibropapillomas could last up to 12 months before regressing 
and all have been associated with BPV-1.
BPV-1 has also been associated with fibropapillomas of the 
teats and udders of cattle. In 1984 Lindholm et al, carried 
out a survey of 1000 cattle and found that 37% had teat 
tumours and of these 28% were attributed to BPV—1. 
Histologically the development of the lesion was identical to
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that of the penile lesion. Three different types of 
papillomas have been found on teats and udders of cattle and 
the associated viruses, BPV-1, 5 and 6 , have been isolated 
and characterised (Jarrett et al, 1980; Campo et al, 1981; 
Jarrett et al, 1984). BFV-5 and 6 will be detailed later.
BPV-2 Tumours 
Cutaneous Fibropapilloma
These tumours are commonly to be found on the forehead, 
neck, upper thorax and back but they can also appear all over 
the body. Again infection appears to depend on the 
concentration and infectivity of the virus as well as the 
depth of the skin scarification made before applying the
virus. They manifest themselves as hard, rough and spherical 
and may number from a few to hundreds. They also may be 
sessile or pedunculated, smooth or or papillomatous depending 
on the stage. The development of the cutaneous fibropapilloma 
is as described for the BPV-1 lesions. By
immunocytochemistry, viral antigen can be demonstrated in the 
cytopathic cells of the stratum granulosum in the final 
stages of development.
Alimentary Fibropapillomas
In an extensive study of papillomas of the upper tract of 
cattle which were processed through the Glasgow Abattoir; 
7,746 animals were examined and it was found that 19% had
tumours (Jarrett et al, 1978) . A further study of 100 
oesophaguses which had tumours revealed that 78% had squamous 
papillomas (BPV-4) and 22% were fibropapillomas which were 
later found to be associated with BPV-2 (Jarrett et al, 1978
and 1984). A detailed study of 60 cases of alimentary
fibropapillomas was embarked upon. These tumours ranged in 
size from 1mm to 30cm and usually occurred in a multiple form
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as against the finding of a single tumour. The lesion was 
white and generally smooth but occasionally ulceration of the 
surface was seen. This benign tumour was found in the 
oesophagus, oesophageal groove and the rumen. Some cases were 
pure fibromas of the subepithelial fibrous tissue. Others 
showed the development of acanthosis (thickening of the 
prickle cell layer), parakeratosis (retention of nuclei in 
the cells of the keratin) and hyperkeratosis (thickening of 
the horny layer) of the epithelium overlying the fibroma; 
pegs of this epithelium branched into the fibromatous tissue. 
Despite the extensive use of immunocytochemical techniques 
with a range of antisera to different BPV's no evidence of 
replicating virus was found. The same result was achieved 
when examined by the electron microscope. However BPV-2 
viral genome was detected by blot hybridization in all of the 
specimens examined ( Campo et al, 1982; Jarrett et al, 
1984). The BPV-2 DNA was present in the fibropapilloma cells 
as multiple episomal copies. When sections were examined by 
in situ hybridization techniques using cRNAs from BPV-1,2,4 & 
5 genomes there was no evidence of a degree of viral DNA 
replication which would be found in a productive viral 
infection; however the tumour cells did contain low numbers 
of episomal copies of the viral genome.
BPV-3 Tumours
This virus was isolated in Germany from a cutaneous papilloma 
found in Australian cattle (Pfister et al, 1979) . The tumour 
appeared as an epithelial lesion with no fibromatous 
component; the virus is distinct from the subgroup members, 
BPV-4 and 6 .
BFV-4 Tumours
Alimentary squamous papillomas are warts of the frond type 
with no fibromatous component or plexiform acanthosis
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(Jarrett et al, 1978) . These alimentary papillomas were 
studied in great detail by Professor W F H Jarrett and his 
group after it was found that large numbers of these wart- 
like lesions were present in alimentary carcinoma cases 
(Jarrett et al, 1978 and 1978b). A very high incidence of 
squamous cell carcinomas of the upper alimentary tract in 
cattle grazing on the bracken infested upland areas of 
Britain was found. As a result an abattoir survey was 
instigated to determine the incidence and aetiology of 
squamous papillomas of the alimentary tract of these areas. 
The upper alimentary cancers were confined to five specific 
sites:
1) dorsum of the tongue - 7%;
2) soft palate - 5%;
3) oropharynx - 8%;
4) oesophagus - 50%;
5) anterior part of the stomach - 30%.
A noticeable feature of these cases were the presence, at the 
same sites as the cancers, of squamous papillomas (Jarrett et 
al, 1978). These benign tumours had not been reported in 
Britain and were not thought to be common in cattle ; they 
have been noted in Germany, America and Kenya (Thorsen et al,
1974) . This was understandable as the majority of cases 
seen in cattle have contained a single lesion and could have 
easily been overlooked. However we have had a few cases 
where several hundred papillomas have been found in the 
mouth, tongue, pharynx and oesophagus.
Alimentary papillomas in cattle are associated with bovine 
papillomavirus 4 (BPV-4 ) ; (Jarrett et al, 1978b) which could 
be isolated from young tumours and were distinguished from 
other BPV's by both molecular biological techniques and by 
immunocytochemical methods (O'Neil, 1982). Alimentary 
papillomas have the typical structure of a frond papilloma.
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Each tumour is composed of a number of sub-units, or fronds 
of transformed cells each terminating in a keratinised tip. 
Virus replicates at an early stage, when cytopathic changes 
are taking place in the immediately sub-keratin layer. This 
appeared in cells which were undergoing cytopathic changes as 
a large intranuclear inclusion body when examined by light 
microscopy. On E.M. examination these inclusion bodies were 
composed of crystalloid arrays of virus particles. As the 
papilloma grew these individual sub-units or fronds extended 
upwards and at this stage there was a lower virus content. 
The virus was restricted to sites of active keratinisation, 
which only occurred between and near the base of the fronds. 
By in situ hybridization techniques there were large copy 
numbers of viral genome found in the keratinocytes, however 
after approximately 8 months duration both replicating virus 
and viral genome was difficult to locate in the epithelium of 
the lesion.
BFV-5 Tumours
"Rice Grain" fibropapilloma is a very common lesion in cattle 
and from this our group has isolated and characterised the 
associated virus which is designated BPV-5 (Jarrett et al, 
1980; Campo et al, 1981). The name "rice grain" was derived 
from the tumour size and the fact that it had a smooth, 
white, elongated appearance. Unlike BPV-1 and 6 induced 
tumours, the rice grain lesion does not adopt the colour of 
the skin in which it is located, but is always white.
This lesion has also three phases of development when studied 
by light microscopy. The first phase that can be visualised 
is a small fibroma of 2-3 mm diameter. Secondly, over this 
fibroma develops a plaque of epithelium, largely 
keratinocytes, about 50 cells thick. This plaque stage has no 
increased granular layer, no cytopathic features and no virus 
replication was visualised either by electron microscopy or
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immunocytochemistry. Thirdly, at a later development stage, 
the granular layer thickens to 2 5 - 3 0  cells. Cytopathic 
changes now appear in the mid-area of this thickened granular 
layer and the keratohyalin granules become large and 
distorted. As the cells migrate towards the surface, virus 
replication could be seen to develop in them, whereas in the 
lower layers there was a marked increase in the genome number 
per cell which could be detected by in situ hybridization. 
This is a very common tumour which often appears as multiple 
papillomas but the majority of animals examined were found to 
have multiple infections i.e. BPV-1, 6 and 5.
BPV- 6 Tumours
There is another very common infection which frequently 
occurs in association with BPV-1 and 5 (Lindholm et al, 1984) 
on the skin of the teats and udder of cattle and is known as 
frond epithelial papilloma. An abattoir survey was conducted 
of 1 0 0 0 unselected slaughtered cattle to determine the 
incidence of BPV infection; and it was found that 37.3% had 
teat tumours and 8 6 .2% of these had multiple infections ; 
BPV- 6 virus was isolated and characterised from 92.3% of 
these lesions.
In pure frond epithelial papillomatosis there is no fibroma, 
no plaque formation and no acanthosis. The tumour has a 
pedunculated base and the line of basal cells forms a curved 
boundary with the underlying normal dermis. The next layer 
consists of keratinocytes which are arranged in columns at 
right angles to the base of the tumour producing the 
individual fronds; similar to those induced by BPV-4. These 
fronds are enclosed by a layer of keratin. Where the fronds 
merge together at the base of the lesion there is an area of 
union of the keratin of adjacent fronds and the underlying 
granular layer where there is also active incorporation of 
keratinising cells into the horny layer: this is called the
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incorporation zone (Jarrett et al, 1984). In experimental 
studies we have shown that virus can be detected quite easily 
in the first 30 days of development of the tumour, when there 
is cytopathic changes occurring in the thickened granular 
layer. After about 90 days a similar pattern to that of the 
BPV-4 lesion emerges. There is a disappearance of virus 
containing cells from the granular-keratin layer interface 
and the areas of viral cytopathic effect are confined to 
incorporation zones.
The Association of Bovine Papillomaviruses with Cancer in 
Animals
Jarrett et al, (1978) showed that in the upland areas of
Scotland and the North of England there is an extremely high
incidence of alimentary cancer in beef cows whereas in the 
lowland areas the disease is virtually unknown. The 
environmental factor which is thought to be involved in this 
phenomenon is bracken fern as the farms with higher 
infestations of bracken inevitably have higher incidences of 
carcinoma and other tumours. Another surprising feature 
evident to the group was that on studying intestinal lesions 
40% of the squamous carcinoma cases had adenomas and 16%
adenocarcinomas of the intestines which were identical in 
type to those found in man (Jarrett, 1978) .
Bracken fern contains a carcinogen that experimentally can
induce tumours in laboratory animals (Evans, 1972) and are 
mutagenic (Bjeldanes & Chang, 1977; Sugimura et al, 1977). 
Bracken feeding can induce urinary bladder neoplasms in 
cattle (Rosenberger, 1971; Pamukcu et al, 1976) and these 
have also been found in the same herds as the squamous 
carcinoma cases investigated by Jarrett and his workers 
(1978). These animals showed clinical signs of haematuria,
haemorrhagic anaemia and a wasting syndrome. 
Experimentally, we have consistently been able to induce, by
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the feeding of bracken for periods of 1 to 2 years,
carcinomas of the transitional epithelium and
haemangioendotheliomas of the subadjacent connective tissue. 
Olson et al, (1959 & 1965 ) and Brobst, (1965) showed that 
suspensions of skin papillomas could induce urinary bladder 
tumours and conversely that suspensions of bladder tumours 
could induce papillomas of the skin. In naturally occurring 
and experimentally induced bladder tumours in cattle, we have 
demonstrated the presence of BPV-2 genome but we have never
been able to locate any replicating virus or viral antigens
(Jarrett et al, unpublished data) . We have also been unable 
to demonstrate papillomavirus genomes in samples of normal 
bladder epithelium.
Bracken fern has induced tumours in mice, rats, guinea pigs 
and quail experimentally (Evans, 1972; Pamukcu et al, 1976; 
Miyakawu et al, 1975) . When fed dried bracken it induced 
intestinal and urinary tumours in rats and lung adenomas and 
lymphoid neoplasia in mice. The milk from bracken-fed cows 
has been implicated in the induction of urinary bladder 
carcinoma in mice and rats. Bracken fern is eaten by humans 
especially in Japan and such preparations retain 
carcinogenicity for rats. Certain areas in Japan have a high 
incidence of gastric carcinomas in humans and there is 
epidemiological evidence to suggest that eating bracken 
increases the risk of oesophageal cancer in the human
(Pamukcu et al, 1976).
The other BPV which offers an excellent in vivo model system 
for the virally induced carcinogenesis story, is BPV-4. 
This has been studied in depth in recent years and it was 
found that there was a high incidence of alimentary squamous
carcinoma in cattle at the same sites where they found the
squamous papillomas (Jarrett et al, 1978). BPV-4 virions
have been isolated from these benign papillomas originating 
in the upper gastrointestinal tract of cattle (Campo et al,
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1980) . However we have never been able to detect BPV-4 genome 
in any of the carcinoma cases that we have investigated. It 
is therefore currently accepted that the BPV-4 genome is not 
required for progression to, or maintenance of the malignant 
phenotype (Campo, et al, 1985). A few hypotheses have been 
offered to explain the interaction of the virus found in pre- 
malignant lesions, and the association of the malignant 
development of the lesions in the presence of bracken fern :
1) BPV-4 acts as an initiator causing changes in cellular 
DNA which is then acted upon by the bracken fern to 
promote a full progression to malignancy.
2) BPV-4 stimulates an increased number of keratinocytes 
and expression of proto-oncogenes, which would increase 
the chances of a malignant conversion if confronted 
with a carcinogen.
Recently in Kenya our group isolated a papillomavirus from a 
lesion of the eyelid in cattle. This papillomatous lesion of 
the periocular skin is very common in Kenya and other sunny 
areas of the world. This lesion was found at the same site, 
ie periocular areas in which squamous carcinoma also 
develops. These lesions are initially found as plaque like 
or papillomatous lesion of the eyelid before the onset of a 
malignant lesions is diagnosed. Australian scientists have 
also isolated a papillomavirus from similar lesions 
(Spradbrow et al, 1983 and 1983b) . The virus we isolated 
has not been characterised therefore the association of the 
virus and the malignant development cannot be explained at 
this moment.
Equine sarcoid is a common tumour found mainly on the legs of 
the horse and donkey. It develops into a fibrosarcoma with a 
form of plexiform acanthosis of the overlying epithelium.
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Olson and Cook (1951) experimentally induced similar
lesionsby intradermal inoculations of bovine papillomavirus, 
which gave credence to the idea that sarcoid tumours might be 
associated with papillomavirus infections. Lancaster and his 
group (1977 & 1979) found the presence of BPV-1 and 2 type 
DNA in both natural and experimental equine tumours.
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CHAPTER 2
DEVELOPMENT OF TECHNIQUES FOR BOVINE 
INFECTIONS
PAPILLOMAVIRUS
Development of Techniques for Bovine Papillomavirus 
Infections
This chapter deals in detail with the development of the 
methodology to purify, transmit, immunise and localise bovine 
papillomavirus antigens.
As in all research into infectious diseases, it is important 
to develop or adapt and improve existing techniques to suit 
the current investigations. The purity and sensitivity of all 
the materials used is extremely important when attempting to 
mimic a natural biological disease and for the understanding 
of the responses.
These techniques are consistent for all the experimental work 
detailed in this thesis unless otherwise stated.
Purification of Bovine Papillomaviruses
Since papillomaviruses cannot be grown in cell culture, virus 
has to be obtained by extraction of tumours. Maximum 
extraction of virus has to be achieved on account of the 
expense that the technique involves; this demanded 
improvement of the maceration methods.
The literature contains many methods for extracting 
papillomavirus but most of these employed as starting 
material, large quantities of pooled tumours from several 
cases of known virus content (Crawford, 1965,; Favre et al,
1975). The use of pooled tumours from different cases was 
precluded in this work because of the possibility of mixing 
different viruses from the same anatomical site (but see 
chapters 3 & 5)
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In any investigation into an infectious disease, the quantity 
and infectivity of the challenge virus, the degree of 
application together with the route of administration of that 
challenge is important. The route of challenge in all the 
experiments was at the same sites as the tumours occurred 
naturally.
Some variability in the infection following application of 
the virus cannot be totally unexpected considering the wide 
range of severity found in natural outbreaks of 
papillomatosis in cattle. Many factors are likely to 
influence the development of these lesions including a) the 
antibody status of the recipient, b) the quality of the virus 
used for transmission and or challenge and c) the amount of 
virus administered. The amount of virus given as a 
transmissible agent or as a challenge dose was difficult to 
quantify and was variable due to many factors; the lack of 
biological assays using cell cultures, the difficulty of 
obtaining virus spreads which give statistically accurate 
virion counting techniques such as latex particle mixing and 
finally the presence of low virus yields from certain tumour 
types.
In view of the relative durability of papillomaviruses, a 
purification method had to be devised which would produce a 
high yield coupled with a high degree of purity without an 
appreciable loss of infectivity. To try and fulfill these 
objectives many methods were attempted and discarded except 
for the following 2 techniques which involved the use of 
dens ity centri fugation.
In the first method of centrifugation, rate zonal separation, 
the sample is layered on to a preformed sucrose gradient. 
Under centrifugal force the particles sediment through the 
gradient at a rate which is determined by their mass and 
size. To achieve separation using this technique, the
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densities of the sample particles must be greater than the 
density of the gradient at any given point and 
centrifugation must be terminated before any of the separated 
zones reaches the bottom of the tube.
In the second method of centrifugation, the isopycnic 
technique, the sample is layered onto a preformed density 
gradient, which encompasses the densities of all particles in 
the sample. The gradient is formed using Caesium Chloride 
solutions of increasing densities. Under centrifugal force 
the particles sediment to the position in the gradient where 
the density of the solution is exactly equal to their own. 
Separation using this technique is on the basis of particle 
density and size only affects the rate at which particles 
reach their position of isodensity. This is independent of 
time, after sufficient time has been allowed for each 
particle to reach its isopycnic position.
Materials and Methods
All tumours were stored in 50% phosphate buffered saline in 
glycerol for fourteen days or more, as this softens the 
tumours and aids the extraction procedure. The tumours were 
collected, unless otherwise stated, from individual animals.
Purification by Rate Zonal Centrifugation
The tumours were cut up finely with scissors before being 
weighed so that the final weight per volume was adjusted to 
10%. Tris buffer (0.1M NaCl, ImM Tris pH 8.0, ImM EDTA) 
containing 0.5% sodium deoxycholate and 0.5% Nonidet 40 
(NP40) was used as the diluent. The tumours were homogenised 
on ice using a Silverson homogeniser for 20 minutes, the 
resultant supernatant being clarified at 2 , 0 0 0 rpm in a bench 
centrifuge for 10 minutes. This was followed by a further
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clarification in a Sorvall OTD 50 ultracentrifuge at 10,000 
rpm for 10 minutes at 4°C, using a SW-41 rotor.
Sucrose velocity gradients were made in SW-41 Ultra-Clear 
tubes (Beckman) by layering 5ml of 10-20% sucrose on top of a 
lml bed of 1.5g/cc caesium chloride (CsCl). The clarified 
material was carefully layered on top of the gradient and 
centrifuged at 40,000 rpm for 20 minutes. The gradients were 
examined against direct light and if in sufficient 
concentration, the virions could be visualised as a light- 
scattering band, which was found at the interface of the 
caesium chloride and the sucrose. The virus was collected by 
piercing the bottom of the tube with a needle. The virus was 
then passed through an equilibrated Sephadex G-25 column. The 
virus was subjected to a further sucrose velocity gradient 
purification procedure as described above, before being 
checked quantitatively by transmission electron microscopy 
using phosphotungstic acid negative staining.
Tris Buffer Saline (TBS) x 10
Sodium chloride 116.9g
Tris 24.2g
Ethylenediaminetetra acetic acid (EDTA) 6.7g
The above chemicals were dissolved in 1900ml of distilled 
water and adjusted to pH 8.0 with concentrated hydrochloric 
acid (HC1) before making up to 2 litres with distilled water.
TBS x 1 for use
To 20Gml of TBS x 10, 1800ml of distilled water was added and 
the pH adjusted to 8.0.
36
20% Sucrose
216.2g of sucrose were dissolved, in 1 litre of distilled 
water and the refractive index was ascertained to be 1.3638 
and the density (D) 1.0829.
10% Sucrose
The 20% sucrose was diluted with equal parts of distilled 
water and the refractive index was ascertained to be 1.3478 
and the density 1.04.
Caesium Chloride - 1.5g/cc
6.7183g of caesium chloride were dissolved in 10ml of TBS so 
that the refractive index was 1.3812.
Purification by Isopycnic Centrifugation
All tumour material to be purified by isopycnic 
centrifugation was initially subjected to a single rate zonal 
separation as described before.
Preformed caesium chloride gradients were made in SW-41 
Ultra-Clear tubes (Beckman) by adding solutions of caesium 
chloride (CsCl) of densities ranging from 1.2g/cc up to 
1.5g/cc. 1.5ml of a 1.2g/cc density CsCl solution was added 
to the centrifuge tube by means of 2mm tubing attached to a 
syringe, which was displaced upwards by 1.5ml of the 1.3g/cc 
density CsCl being added to the bottom of the tube. This 
procedure was repeated until the 1.5g/cc density CsCl 
solution was in place. The gradients were allowed to form for 
24 hours at 4°C before using. Before use a 1ml layer of a 
1.2D sucrose solution was gently added to the top of the
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caesium gradient to prevent disruption of the preformed 
gradient by the addition of the zonal purified virus 
suspension. Finally 5.0ml of virus suspension was added to 
each gradient and centrifuged at 40,000 rpm for 18 hours. The 
gradients were examined against direct light and if in 
sufficient concentration, the virions could be visualised as 
a light-scattering band, which was found at the interface of 
the caesium chloride and the sucrose. If no light-scattering 
band could be seen the gradient was then fractionated into 10 
drop aliquots by piercing the bottom of the tube with a 
needle, which were then examined by a refractometer to 
establish the respective refractive indices of the serial 
samples. Virus was located in the region of 1.32g/cc. The 
appropriate virus fraction was dialysed against Tris buffer 
overnight at 4°C with continuous agitation before being 
examined by transmission electron microscopy.
Caesium Chloride (CsCl)
Caesium chloride solutions were prepared by dissolving the 
following weights of CsCl salt in 10ml of distilled water.
1.2D - 2.77g
1.3D - 4.02g
1.4D - 5.48g
1.5D - 6 .73g
Sucrose - 1.2D
5.2g of sucrose were dissolved in lOmls of distilled water.
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Phosphotungstic Acid Negative Staining
Materials:
An aqueous solution of 2% phosphotungstic acid (PTA) at pH 
7.2 was freshly prepared. Grids were coated with a very thin 
parlodion support film. To stabilise the plastic film the 
grids were coated with a thin film of carbon (approx. 50A°) 
over the parlodion.
Parlodion solution
A 3% stock solution of parlodion in amyl acetate was made by 
dissolving 0.3g parlodion pieces in 10ml of amyl acetate and 
allowed two days to dissolve. 0 .6% is used for coating the 
grids, i.e. 0.2ml stock 3% parlodion solution diluted with 
0 .8ml amyl acetate.
Method:
1) One drop of the virus material was dispensed on to a
grid using a micro-pipette.
2) This was kept at room temperature for 2 minutes before
removing the excess fluid with filter paper.
3) One drop of 2% PTA solution was added and kept for 2
minutes at room temperature. The excess fluid was 
removed with filter paper.
The grid was examined on a Zeiss 109 electron microscope.
If a sample contained any traces of caesium chloride it was 
rinsed for one minute with 0.15M ammonium acetate.
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Conclusion
From repeated purification attempts of bovine papillomavirus 
from tumour material it would appear that rate zonal
centrifugation can produce a relatively high yield of virus 
without an appreciable loss of infectivity. This has been 
substantiated by the viruses ability to be experimentally 
transmitted to other cattle, by the high titre antibody
levels obtained after immunising rabbits, and when examined 
by other immunological techniques (ELISA & Western Blot), 
details of which are not covered in this thesis. However 
there are present, in the virion sample purified by rate 
zonal centrifugation, intermediate fibres from keratinocytes. 
These filaments obviously have the same buoyant density and 
as such cannot be eliminated.
Virus samples which contain these contaminants can readily be 
purified by subsequent isopycnic centrifugation but in our 
hands the resultant virus is less antigenic and is unsuitable 
for certain procedures and assays (tissue culture, AGID and
raising mono-specific antisera), details of which are not
covered in this thesis. At the onset of this virus 
purification procedure , three criteria were established; a 
high yield; a high degree of purity; and a regime which will 
not appreciably affect the infectivity. These criteria appear 
to be fulfilled, especially by the rate zonal centrifugation 
method, which has been successfully applied to the majority 
of the work presented in this thesis (Figure 1) .
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Figure 1: Bovine papillomavirus purified by rate zonal
centrifugation and negatively stained by PTA. (x 100,000).
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Raising Antisera to Bovine Papillomavirus
As described in chapter 1, 5 BFV's have been found associated 
with a number of lesions in cattle in the U.K. (Jarrett,
1981). Papillomaviruses from different species are 
immunologically distinct and antisera raised against intact 
virions show homologous reactivity but no heterologous cross­
reactivity. Shah et al., in 1979 and Jenson et al., in 1980 
used BPV-1 and HPV-1 disrupted by sodium dodecyl sulphate 
(SDS) and demonstrated cross reactivity by 
immunocytochemistry.
Young, healthy rabbits were selected and 20ml of blood was 
removed and the serum collected. This pre-immunisation serum 
was subsequently used as a negative control serum for each 
specific rabbit antisera produced.
Virus was purified as described by zonal and isopycnic 
density gradient centrifugation. For practical purposes we 
have used preparations whose viral content has been estimated 
by EM negatively stained preparations. The preparations that 
were used to immunise the rabbits contained approximately 
1011 to 1012 particles per ml.
Before administering the virus plus Freund's adjuvant, it is 
necessary to determine the integrity of the emulsion by 
allowing a drop of the suspension to fall onto the surface of 
cold water. If the droplet remains intact this indicates that 
the aqueous phase containing the antigen is entirely closed 
within the oil and it is now fit to use.
Two different sets of antisera were raised ;
1) mono-specific
2) cross-reacting ("split")
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The method of injection, site and timing is the same for both 
types of antisera.
Mono-Specific Antisera
The primary injection consisted of 1ml of purified whole 
virus suspension with an equal volume of Freund's complete 
adjuvant (Miles Laboratories Ltd.) . There were two further 
booster injections at weekly intervals with equal volumes of 
virions and Freund's incomplete adjuvant. The injections were 
administered deep into the right and left quadricep muscles. 
Ten days later, the rabbit was bled, by nicking the marginal 
vein of the ear. Two universals of blood were taken (40ml) 
and the serum obtained provided the initial batch of rabbit 
anti-bovine papillomavirus antisera. This was aliquoted, 
labelled and stored at -20°C until required. After a lapse of 
12 weeks the rabbits were again boosted with an equal volumes 
of virions and Freund's incomplete adjuvant.
Cross-Reacting ("Split") Antisera
The purified BPV virions were disrupted with sodium dodecyl 
sulphate (SDS) and mercaptoethanol (ME) (Favre, et al, 1975) . 
0.3ml of purified virus was mixed with 30ul of 10% SDS and 
5ul ME and boiled for one minute. The suspension was brought 
up to 1.2ml with phosphate buffered saline and emulsified 
with an equal volume of Freund's adjuvant. The procedure is 
the same as for the mono-specific antisera.
Conclusion
Using the PAP technique to evaluate response, it was found 
that high titre, cross—reactive antisera was consistently 
being obtained when virions purified by isopycnic
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centrifugation and disrupted by SDS were used. On the other 
hand there was a very poor antibody response when mono­
specific antisera were raised using isopycnic centrifuged 
virions. The caesium chloride obviously had an adverse effect 
on the infectivity of the viral capsid antigen. Details of 
this work are not included in this thesis.
After many immunisation attempts it was decided to use a 
double rate zonal centrifugation purification procedure even 
although there are contaminants present in the antigen 
preparation which will produce an antibody response. These 
contaminating antibodies are easily diluted out when high 
titre specific antisera was raised. Antibody levels in 
antisera raised against disrupted virions as determined by 
the PAP technique were consistently > 1:500,000.
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Tii>munocytochemical Local isation of Bovine Papillomaviruses
Immunocytochemistry is one of the most sensitive research 
tools available. Its potential for localising various 
antigens at the light microscopical level provides us with 
correlation between structure and function which is necessary 
in biological research.
Antibodies were raised by immunising rabbits with an antigen 
purified as highly as possible. The resulting antiserum is 
not directed solely to the desired antigen as a single 
antigen molecule contains several characteristic determinants 
or epitopes and will also contain many "natural" antibodies, 
which may or may not react with tissue components. Since 
there are many B-cells producing antibodies against each 
epitope, this is termed a polyclonal (many cells) antibody. 
In this thesis the research findings are based on the use of 
polyclonal antibodies only ; they have proved to be 
accurately defining virus types with the exception of BPV-1 
and 2 which share major antigens. Immunocytochemistry 
requires antibody to be of high affinity for its antigen, 
in other words that its binding sites fit well with the 
antigenic sites on its specific antigen and do not attach to 
other antigens ? as well as the avidity, or binding strength. 
A high titre antiserum will allow a higher dilution to be 
made, which will enable the unwanted or non-specific 
antibodies, which might react with tissue components, to be 
diluted out.
Whilst the immunoperoxidase techniques have many advantages, 
some technical difficulties may be encountered with the 
procedures. Tissue sections require, in most cases, pre- 
treatment with trypsin to unmask cross linked antigenic 
determinants. In addition, endogenous peroxidase activity has 
to be quenched if not comp 1 ete 1 y eliminated. Finally, you
45
have to include three control sections with every procedure 
to ensure the specificity of the reaction. However, this is
more than compensated for in the final result, as it is now
possible to distinguish and localise specific 
papillomaviruses.
The major advantage of the technique is that many antigens 
and not only viral antigens can be demonstrated in routine 
paraffin embedded material which had been formalin fixed 
(Stemberger, 1979) . This facilitates the use of 
retrospective studies of material which has been stored.
Of the numerous immunocytochemical methods available for 
visualisation of antigens the peroxidase anti-peroxidase 
(PAP) technique was found to be the method of choice for all 
the experimental work detailed in this thesis. This technique 
was employed on formalin and corrosive formol fixed material, 
which was then embedded in paraffin wax.
The method is described on the following page.
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Immunoperoxidase Technique (ESFJ Mapted from Stemberger,
1974
1) The sections were depai^ffiitised in sryl^ae and 
rehydrated in alcohol.
2) They were then immersed in Lugol's iodine followed by 
immersion in 5% sodium thiosulpfaate to remove mercuric 
chloride artifact, followed by a wash in nurmimg tap 
water.
3) Endogenous peroxidase was inhibited by treating with 
freshly prepared 0.5% hydrogen peroxide (H2G2) in 
methanol for 30 minutes.
4) The sections were then washed well in distilled water.
5) The temperature of the slides was equilibrated in 
distilled water at 37°C for ten minutes.
6) Sections were treated with 0.1% trypsin in 0.1% calcium 
chloride (adjusted to pH 7.8 with N/10 NaOH) for 30 
minutes at 37°C.
7) The sections were transferred to cold distilled water 
with agitation for 2-3 minutes.
8) Sections were washed in two baths of Tris buffered 
saline (TBS) pH 7.6 containing 1% normal swine serum 
(TBS/NSS) for 5-10 minutes each (to reduce the staining 
of non-specific tissue binding sites).
9) The primary antiserum, Rab/BFV, at optimal dilution was
applied The diluent used was TBS containing 0.1% bovine 
serum albumin (BSA) and 0.01% sodium azide (this 
solution prevents the proteins from adhering to the 
glass) - 1 hour. Overnight incubation was used with
higher dilutions.
10) The sections were washed in two baths of TBS/NSS for 10 
minutes each.
11) The bridging antibody ; swine anti—rabbit IgG at 1/20 
dilution was applied for 60 minutes.
12) Sections were washed in two baths of TBS/NSS for 10 
minutes each.
47
13) The PAP (peroxidase/rabbit anti-peroxidase) at 1/20
dilution was applied for 30 minutes.
14) The sections were then washed in two baths of TBS for
10 minutes each.
15) The peroxidase reaction was developed with DAB (Graham 
and Karnovsky, 1966) for up to 5 minutes before ;
16) Washing in TBS followed by washing in distilled water.
17) The preparation was counterstained with Mayer's 
haematoxylin and differentiated in 1% hydrochloric acid 
in alcohol before blueing in Scott's tap water 
substitute (STWS).
18) The sections were dehydrated through meth. spirit and
alcohol before ;
19) Clearing in xylene and mounted with a resinous medium.
Result : Peroxidase activity stained brown.
Controls :
The following were routinely employed when performing the
technique.
1) Known positive control tissue was included to eliminate 
technical error.
2) Primary antibody was omitted to check endogenous 
peroxidase activity and the non-specific binding of the 
secondary antibody.
3) Both the primary and the bridging antibody were omitted 
to ensure there was no cross-reaction between the 
rabbit peroxidase anti-peroxidase and the antigens on
the tissue section.
4) The primary antibody was omitted but was substituted by 
the pre-immunisation serum from the rabbit.
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Materials
10% Buffered formaldehyde (pH 7.0).
Sodium dihydrogen orthophosphate 
Disodium hydrogen orthophosphate
4.0g
6.5g
The above chemicals were dissolved in 900ml of distilled 
water and 100ml of formaldehyde added.
Corrosive formol.
100ml of formaldehyde was added to 900ml of saturated 
mercuric chloride.
Tris/HCl buffered saline (TBS) pH 7.6.
The following chemicals were dissolved in 10 litres of
distill®! water :
Sodium chloride 80. Og
Tris (Tris hydroxyietliyl methylamine) 6.05g 
Finally 38ml of W hydrochloric acid was added.
DAB (Graham and Kamcvsky)
25iig of 3r3' dianminobenzidine tetrahydrochloride was 
dissolved in 50ml of 0.05M, pH 7.6 Tris/HCl buffer and 0.15ml 
of 3% hydrogen peroxide was added immediately before 
immersion.
Tris/HCl buffer for DftB
I2imi of 0.21 Tris (2 4 .2 2 8gm/litre) and 19ml of 0.IN HC1 was 
added to 19ml of distilled water. The pH was adjusted to 7.6.
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Mayer's haematoxy 1 in.
The following were dissolved in 1 litre of distilled water :
Scott's tap water substitute (STWS).
The following chemicals were dissolved in 1 litre of 
distilled water :
Sodium bicarbonate 3.5g
Magnesium sulphate 20 g
The swine anti-rabbit bridging antibody and the PAP (rabbit) 
were both supplied by Dakopatts Ltd.
Conclusion
The PAP technique has many advantages over previous 
immunocytochemical methods and has replaced fluorescein as 
the antibody label of choice in many circumstances. From the 
results obtained in the experimental material detailed later 
in this thesis, it is evident that the PAP technique has 
three major features. The first is its permanence; where 
sections may be prepared and stored for retrospective 
studies. The second feature is that excellent histological 
definition is possible since formalin fixed material is 
suitable for this technique, which greatly facilitates the 
identification of the virus containing cells and its
Haematoxylin 
Sodium iodate 
Potassium alum 
Citric acid 
Chloral hydrate
l.Og
0.2g 
50 g
1. Og 
50 g
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location. Thirdly and most importantly is the sensitivity of 
this technique, which enables the recognition in fixed tissue 
of antigenic sites.
Having developed the immunoperoxidase technique for the 
detection of papillomavirus infections in cattle, it was now 
possible to locate precisely the antigen distribution and its 
relationship to the development of the lesion.
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CHAPTER 3
EXPERIMENTAL TRANSMISSION OF BOVINE 
INFECTIONS
PAPILLOMAVIRUS
Introduction
It is well established in the case of HPV and the BPV systems 
that there are numerous virus types (i.e. at least 7 bovine 
associated viruses and 51 human associated viruses) .
It was of major importance to establish whether the immune 
and protective phenomena were induced by group specific or 
type specific antigens and whether there was any degree of 
cross-immunity between types within a species.
Obviously this would be extremely difficult to investigate in 
humans and the bovine is the only animal species in which 
this could be attempted at the moment as several 
manifestations are common to the two systems; multiple virus 
types, specificity of lesions, malignant progression of some 
papillomas and the involvement of co-factors.
This is of major importance in putative vaccination for the 
future. It was therefore decided that the aims of this thesis 
were to be three-fold;
1) To study the development of BPV induced tumours and 
their virus cycle.
2) To determine whether the resistance to bovine 
papillomavirus induced infections is by group or type 
specific antigens.
3) To determine the efficacy of several prophylactic 
vaccination regimes.
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Experiment 1.
Experimental Transmission of Bovine Cutaneous Fibropapilloma 
by BPV—2
BPV-2 is associated with cutaneous fibropapilloma found on 
all parts of the body but mainly on the forehead, neck, upper 
thorax and back of cattle. These infections can last for 
anything up to one year before spontaneously regressing but 
occasionally some animals are unable to reject the infection 
and have to be destroyed because of the widespread nature of 
the lesions. In the following sets of experiments we have the 
opportunity to study both the tumour cycle; infection -> 
tumour induction -> tumour regression -> reinfection; and the 
immunity to papillomavirus infections.
Materials and Methods
Calves
Two calves were purchased from a reputable dealer who 
previously clinically examined both the calf and the dam and 
were selected as being free of any obvious papillomavirus 
infection. They were 12 week old, male, Ayrshire cross 
calves and on arrival they were immediately housed in a 
clean, well ventilated pen in the isolation unit. They were 
then bled for both haematological analysis and for serum, the 
latter being stored at -20°C for future studies. Three weeks 
later, when the calves were 15 weeks of age and the maternal 
antibodies were assumed to have disappeared, the experiment 
was initiated. These calves (49 & 50) were originally
involved in the cell membrane vaccine experiment which will 
be discussed later. Serial biopsies were used to detail the 
development of the lesions.
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BPV-2 Virus Preparation
Virus was purified froiti a fully developed cutaneous 
fibropapilloma of the upper body of a cow (76119/10) as 
described on page 33 using rate zonal centrifugation. A 
sample of the resultant virus was sent to Dr S. Campo for 
restriction mapping and hybridization and was subsequently 
confirmed as containing only BPV-2 genomic DNA. A sample of 
virus was also sent to Dr H. Laird for quantitative 
estimation by TEM using phosphotungstic acid negative 
staining. The virus content was estimated to be approximately 
1012 particles per ml. This calculation is based on the 
finding that when 1 or 2 particles are found per grid square 
in a neat virus preparation, this represents approximately
Q , ,
10 particles per ml. This virus, with 6 grids for each
. . .  . . — ?dilution, still had particles m  the 10 dilution thus
1 9giving a total of 10 particles per ml.
BPV-2 Transmission Site
The animals were anaesthetised using 3ml of Rompun (Bayer) 
intramuscularly (IM) , before shaving the left side of the
neck. The skin was then cleansed with ether before 3 x 4  inch 
vertical scarification lines were made with the aid of a
needle. The depth of the wound is important, as discussed in
the literature review and it was found to be necessary to
draw blood when scarifying. The neat virus was run into the 
resultant grooves.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun before surgically 
removing a small representative piece of tissue for 
histological examination. All biopsy material was fixed in 
10% buffered neutral formalin (BNF) followed by post fixation 
in corrosive formol. The material was then processed for
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in corrosive formol. The material was then processed, for 
embedding in paraffin wax. The sections were initially 
stained by haematoxylin and eosin (H & E) . Further studies 
using peroxidase anti-peroxidase (PAP) technique were 
carried out with "split" (cross-reacting) BPV-2 antisera.
Results
In both calves tumour development was first identified 
macroscopically at 7 weeks after challenge. There was a 
linear reaction on all lines of scarification, measuring 
approximately 1cm wide and raised about 0.5cm above the 
adjoining skin.
The biopsy showed that the lesion consisted of a fibroma, 
which was invading between the already existing adnexi. Among 
the fibromatous tissue could be seen hair follicles. It was 
surrounded by normal tissue and dilated lymphatics. The 
epithelium was thin and showed no rete-peg formation or 
cytopathic changes (Figure 2) . This appears as Stage 1 in the 
development of a fibropapilloma.
Using antisera raised to disrupted BPV-2 virions, no viral 
antigen could be detected at this stage by the peroxidase 
anti-peroxidase (PAP) technique. (Raising antisera and the 
PAP technique are described fully in chapter 2).
When examined at 8 weeks post challenge, the depilated
lesions were easily seen and were uniformly linear. The
epithelium appeared to be rough but no obvious
papillomatosis. These fibroma-like lesions were approximately 
lcm wide and projected 2 to 3mm from the surface. The lesions 
appeared to be hyperkeratotic.
Histologically this was a fibropapilloma. There was
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thickening of ths keratinocyte layer of the epithelium plus 
the formation of a downgrowth of this epithelium into the 
fibromatous tissue, which was termed plexiform acanthosis. 
There was also disruption of the continuity of the basal cell 
layer and the presence of melanin containing cells throughout 
the epithelium. Over the lesion there was hyperkeratosis and 
parakeratosis. There was no marked cytopathology but there 
were indications of viral proliferation in a small area of 
the lesion (Figure 3). This indicated a late Stage 2 or 
early Stage 3 fibropapilloma.
When examined by PAP, using cross-reactive antisera, there 
were a few cells expressing viral antigen but they were not 
heavily laden. These viral antigens were seen in the 
uppermost cells of the granular layer.
At 11 weeks post challenge stage there were prominent tumours 
on all three lines of scarification. They were depilated and 
markedly papillomatous and measured approximately 2cm wide.
Microscopically the tumour was a well developed 
fibropapilloma. It had a very active and cellular fibromatous 
component, overlayen by a hyperkeratotic epithelium which was 
showing papillomatosis. There was a marked thickening of the 
keratinocyte layer extending in long pegs into the fibroma 
and showing some degree of plexiform acanthosis. Both the 
basal cells and the keratinocytes showed a fairly high 
mitotic rate. In the upper keratinocyte layer of the
epithelium there was cytopathic changes occurring. This was 
seen as vacuolation of the cytoplasm, margination of the 
chromatin and diminution in size of the nucleoli. The
keratohyalin granules were highly irregular and appeared 
scattered over the cells and in the incorporation zones they
had increased in size to approximately a quarter of the
nuclei size. The underlying fibroma was composed both of 
collagen-producing cells and active fibroblasts. There was
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marked parakeratosis.
When examined by the PAP technique there was no staining in 
any fibroma cells, basal cells or in the keratinocytes which 
formed the rete-pegs. However positivity did appear at about 
5 cells from the keratinising layer in the granular layer. 
This was very light staining but above these cells where the 
cytopathic changes were distinct, the nuclei were relatively 
devoid of structure and there was heavy antigen deposition. 
There was also positive antigen reaction in the long thin 
cells of the parakeratotic horny layer (Figures 4 & 5) .
In calf 49 after 13 weeks post challenge the lesions were 
clearly papillomatous, raised and depilated.
Histologically this was a well developed fibropapilloma with 
no remaining adnexal elements in it. The fibromatous 
component was not as active with fewer fibroblasts present 
but had markedly more collagen-producing cells. There was 
still a markedly thickened keratinocyte layer. Obvious 
cytopathology was present throughout the length of the biopsy 
and viral antigen was demonstrated by the PAP technique. The 
virus was located in the upper granular layer of the tumour 
and was in abundance.
However in calf 50 a different stage of events was apparent. 
The lesions were depilated and papillomatous but were not as 
protruding as calf 49.
Microscopically the lesion was also different. There was no 
thickening of the squamous epithelium, no plexiform 
acanthosis and the basal cells were regular and uniform in 
appearance. Remnants of cytopathic cells were found in the 
upper granular layer but there was no parakeratosis or 
hyperkeratosis present. In the sub-epithelial tissue the 
remaining fibroblasts were active but fewer in number. There
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was obvious deposition of collagen which in areas was 
undergoing hyalinization. Also present in the fibroma was a 
massive proliferation of lymphocytes around the vessels. 
Numerous hair follicles were present in both the epidermis 
and dermis. This lesion was obviously in a regression state. 
When examined by the PAP technique no viral antigen was 
detected.
When examined at 17 weeks post challenge, the lesions in both 
calves appeared to be regressing markedly, especially calf 
50. The surface was hyperkeratotic and the fibromatous 
component smaller in content.
Histologically the lesions differed dramatically. In calf 50, 
this selected biopsy showed no linear thickening of the 
granular layer; however there were several acanthotic areas 
and many papillomatous protrusions. There were also numerous 
degenerative, cytopathic cells. The lesion was hyperkeratotic 
but had no evidence of parakeratosis. Sub-epithelially the 
fibroma had been largely replaced by collagen and there was a 
return of the adnexal elements. There was a proliferation of 
lymphocytes and macrophages in the perivascular connective 
tissue but not as marked as in the 13 week biopsy. This 
biopsy appeared to show the final stages of regression. No 
viral antigen could be detected by the PAP technique.
On histological examination, the biopsy from calf 49 revealed 
a Stage 3, fully developed, cutaneous fibropapilloma. There 
were present both in the epithelium and the sub-epithelial 
tissue, hair follicles and aggregates of lymphocytes. 
Throughout the length of the tumour there were aggregates of 
irregular shaped keratohyalin granules present in the upper 
granular layer as well as cytopathological changes. 
Immunocytochemical analysis revealed a virally productive 
tumour with no obvious diminution in yield of antigen.
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At the 19th week the lesions were depilated, hyperkeratotic 
and smaller in size.
Microscopically calf 50 biopsy consisted of a hyperkeratotic 
lesion with no fibromatous component. There were remnants of 
lymphocytes and macrophages but no thickening of the 
epithelium and the lesion appeared to be in a degenerative 
state. No viral antigen could be seen when examined by the 
PAP technique.
In contrast the biopsy from calf 49 still appeared as an 
active fibropapilloma but the epithelium was not so markedly 
thickened. There was lymphocyte infiltration in the 
epithelium but the cytopathic changes still persisted. The 
lesion was hyperkeratotic. Immunoperoxidase still revealed 
active viral production but the intensity of the reaction and 
the abundance of antigen was apparently decreased and was 
obviously related to the sequence of regression.
On macroscopic examination at week 25, calf 50 had no visible 
lesions. Hair growth was restored and the site was 
completely healed. No further biopsies were taken.
Calf 49 still had prominent ridges on the lines of 
scarification, which were 2cm broad and raised. They were 
depilated, hyperkeratotic, fully developed papillomas.
Histologically the epithelium was still markedly thickened 
but there was an intense proliferation of lymphocytes and 
macrophages as well (Figures 6 & 7) . There was also the re- 
emergence of skin adnexal elements in one area of the 
squamous epithelium. In the sub-epithelial tissue there was a 
large infiltration of lymphocytes alongside highly active 
fibroblasts as well as the appearance of numerous hair 
follicles. Although this lesion was obviously in a regressive 
state, when examined by the PAP technique it was still a
59
virally productive one.
At the 35th week there were still three rows of well 
demarcated, typical, fibropapillomas present. They were 
depilated, hard and very scaly when touched.
Histologically it appeared as a hyperkeratotic, papillomatous 
lesion with no fibromatous component except for the 
connective tissue papillae. Although there were cytopathic 
cells present there was no viral antigen demonstrated by the 
PAP technique.
By the 40th week calf 49 still had three lines of papillomas 
which were 2cm high x 2cm wide. They had become markedly 
papillomatous with thick fronds which were easily broken off.
On histological examination it presented itself as a 
hyperkeratotic, filliform lesion with little or no connective 
tissue. Where there was a remnant of sub-epithelial tissue it 
contained masses of lymphocytes and macrophages and the 
lesion appeared degenerate. There was no viral antigen 
detected by the PAP technique.
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Figure 2: Early stage development of a fibropapilloma induced 
by BPV-2. Prominent proliferation of fibroblasts and minimal 
effect on the squamous epithelium. H & E.
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Figure 3: A later stage in development of the tumour in
Figure 2 showing the interface of Stages 2 & 3. Keratinocyte 
proliferation with thickening and cytopathic changes in the 
granular layer. Obvious hyperkeratosis present. H & E.
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Figure 4: Immunocytochemical staining of a BPV-2 papilloma at 
Stage 3, showing the restriction of the viral antigen to the 
granular layer. PAP.
i jp
■s
t
£K*
..v
&  ■ ■ 4 'V ■ -=■ i*
'* ) 4 4- ’ ' --- -- .
- r " v:- ii/r!5”-' i ‘ I
* a ' • a >,.%• ‘ '• -• ss'-- .• (v>, ;> \ m
-Vi% - .V. * *
« K ‘ • . ' •» • .. ?'  ^ • f
- r ,V -
vs-
______________-/ . .1 4^ ’  ^ A___1-- ---- ------------------ - --------------- -
Figure 5: A higher magnification of Figure 4, demonstrating 
the restriction of antigen to the granular layer nuclei. PAP.
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Figure 6: The start of the rejection phase. Heavy mononuclear 
infiltrate of the previous fibroma below the acanthotic 
epithelium. H & E.
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Figure 7: A higher magnification of Figure 6, showing
invasion of the proliferated epithelium by macrophages & 
lymphocytes. H & E.
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Experiment 2
Experimental Transmission of Bovine A1 iTnpirhary Papilloma by 
BPV-4
BPV-4 is associated with epithelial papillomas of the 
alimentary tract in cattle. These lesions are of the frond 
type with no fibromatous component and no plexiform 
acanthosis. They were found in association with alimentary 
squamous carcinomas in high incidence cancer areas. It is 
this synergistic mechanism which is of interest to 
scientists.
When purifying virus from tumours of unknown content, it is 
important to study the development of the lesion to ascertain 
the differentiation process in relation to virus production 
and to determine if this was related to ageing. This small 
experiment allowed the study of an experimentally induced 
BPV-4 tumour cycle without the use of co-factors (bracken or 
immunosuppression).
Material and Methods
Calf
This calf (72) was purchased from the same dealer as the 
previous experiment and was selected by clinical examination 
as being free of any obvious papillomavirus infection. The 
calf was a 13 week old, male, Friesian and on arrival was 
immediately housed in a clean, well ventilated pen in the 
isolation unit. It was then bled for both haematological 
analysis and for serum, the latter being stored at -20 C for 
future studies. Two weeks later the experiment was started.
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BPV-4 Virus Preparation
The BPV 4 transmission virus was purified from a pool of 
bovine oesophageal papillomas obtained from the Glasgow 
abattoir. These tumours were stored in 50% PBS/Glycerol at 
4°C until required for purification.
BPV—4 tumours (4g) were homogenised in a Silverson grinder, 
using 20ml of PBS as diluent. The suspension was clarified at 
2,000 and 10,000 rpm for 10 minutes each. The supernatant was 
purified by rate zonal centrifugation as described on page 33 
and the resultant virus content was estimated by 
phosphotungstic acid negative staining on the TEM and quantal 
evaluation.
BPV-4 Transmission Site
The calf was anaesthetised with 3ml of Rompun (IM) and 
immediately before administering the virus, 2ml of Brietal 
Sodium was given (IV) . 5ml of the purified BPV-4 virus was 
inoculated into the soft and hard palate by numerous intra- 
mucosal injections. At regular intervals, determined by the 
development of the tumours, the calf was clinically examined 
and bled for both haematological analysis and serum.
Surgical and Histological Procedures
The calf was anaesthetised with Rompun and Brietal before 
surgically removing a lesion with the aid of a 3mm biopsy 
punch. The biopsy was fixed in 10% BNF followed by post 
fixation in corrosive formol. The material was then processed 
for embedding in paraffin wax. The sections were initially 
stained by H & E. Immunocytochemical localisation of the 
viral antigen was demonstrated by the PAP technique using 
type specific antisera.
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Results
A mouth examination was carried out 2 weeks after the virus 
was administered and found numerous, small, opalescent 
lesions at the sites of injection. No biopsy was taken.
At 5 weeks there were numerous small, translucent, projectile 
lesions on the palate and pharynx - all injection sites. No 
biopsy was taken.
Under anaesthetic, at 6 weeks post transmission, a mouth 
examination revealed the presence of distinct, multi-fronded 
papillomas at the sites of injection. A biopsy was taken for 
histological examination.
Microscopically this biopsy showed the earliest developmental 
stage of an alimentary papilloma. There was obvious 
keratinocyte proliferation with dyskeratosis and the early 
formation of the fronds from the base of the papilloma. There 
was also parakeratosis present at the tips of the frond but 
not at the incorporation zones or at the keratinocyte / 
keratin border (Figures 8 & 9) . In the incorporation area 
there was however evidence of the formation of inclusion 
bodies, which were indicative of virus presence (Figure 10). 
This was confirmed by the PAP technique using antisera raised 
to disrupted BPV-4 virions. There were many cells in the sub­
keratin layer and the incorporation areas were expressing 
viral antigen but not strongly as indicated by the light 
nature of the reaction.
At 9 weeks calf 72 was subjected to another mouth 
examination. This revealed numerous, small but distinct, 
multi-fronded papillomas on the palate. A punch biopsy was 
taken for histological examination.
Histologically this biopsy appeared to be bigger in size in
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comparison to week 6, with the base broader and the fronds 
longer. The fronds were well developed and had fully 
keratinised tips instead of the parakeratosis seen in the 
previous biopsy. There were marked incorporation zones 
present coupled with parakeratosis. The PAP technique 
localised the associated viral antigen in the many flattened 
nuclei in the keratin and the sub-keratin layer. There was a 
positive increase in the number of virally active cells 
present compared to week 6.
The mouth examination at week 12 was very similar to the 
previous one except there was a wide range of papilloma 
sizes covering the palate.
Microscopically the lesions appeared as well developed 
epithelial papillomas (Figure 11) . On the H & E section, 
inclusion bodies were easily identified in the cytopathic 
cells present in the incorporation areas. 
Immunocytochemically viral antigen was confirmed in these 
cells as well as well as the sub-keratin areas of the fronds.
When examined at 16 weeks post transmission, there were still 
present numerous, filliform papillomas on the palate.
Histologically these lesions appeared as well developed 
papillomas but were larger than previous biopsies. There was 
a marked mitotic activity in the basal and parabasal layer 
which gave rise to a large number of keratinocytes in the 
immediately overlying area. On the H & E stained section 
there appeared to be large numbers of cytopathic cells 
present in the incorporation areas. This observation was 
supported when the PAP technique was applied except that the 
cells which were positive only gave a faint signal.
The 21 week mouth examination revealed numerous, blunted, 
filliform papillomas on the palate.
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Histologically, including the inununocytocheinical examination, 
a similar finding to the 16 week biopsy was seen.
At the 26 week mouth examination there were still numerous, 
blunted, typical BPV-4 induced papillomas on the palate.
Microscopically these tumours are larger with many more 
fronds arising from the base. There are still many cytopathic 
cells present in both the sub-keratin and the incorporation 
areas. However it was mainly the cells in the keratin and 
sub-keratin areas which showed any strong positivity although 
it was not as abundant as in previous biopsies. In the 
incorporation areas there was a faint reaction which probably 
represented the remains of a viral infection as against an 
active infection.
This calf was subjected to further examinations at 30, 35, 41 
and 52 weeks and there was no diminution in the numbers of 
papillomas, nor was there any change in the histological 
structure of the lesions. When examined by the PAP technique 
no viral antigen was expressed in any of the biopsies 
examined.
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Figure 8: Earliest development stage of a BFV-4 lesion. 
Plaque of proliferated keratinocytes with only the earliest 
signs of papilloma development. H & E.
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Figure 9: A higher magnification of Figure 8,
thickening of the alimentary-specific granular layer.
showing 
H & E.
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Figure 10: A developed BPV-4 papilloma showing the virus 
producing incorporation zone (bottom, centre) and the typical 
frond structure. H & E.
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Experiment 3
Experimental Transmission of BFV-5 and BPV-6 Tumours by the 
Type Specific Virus
BPV-5 and BPV-6 are associated with the rice-grain 
fibropapilloma and the squamous papilloma respectively, found 
on the teats and surrounding skin of cattle. They are very 
common lesions and often appear as multiple infections with 
each other and also with fibropapilloma induced by BPV-1. Due 
to the small size of the rice-grain tumour and the mode of 
development it has proved to be very difficult to obtain 
sufficient virus for biological studies. There was also a 
numerical lack of BPV-6 lesions to facilitate adequate 
studies and as a result, the rice-grain lesions and the 
squamous papillomas had to be pooled (separately) in order to 
overcome this problem.
The object of these experiments was to induce numerous rice- 
grain and squamous papillomas with purified BPV-5 and BPV-6 
virions to study the tumour cycle and provide a source of 
material for future vaccine studies.
Material and Methods
Calves
Four calves were purchased from the same source as the 
previous experiments. These calves were not in contact with 
other animals and were selected as being free of any obvious 
papillomavirus infection by clinical examination. The calves 
were 10 week old, male, Friesians and on arrival were 
randomly selected into 2 groups, which were then housed in 
separate, clean, well ventilated pens in the isolation unit.
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They were immediately bled for both haematological analysis 
and for serum, the latter being stored at -20°C for future 
studies. The experiment was initiated when the calves were 15 
weeks old.
Group 1) BPV-5 transmission calves - 61 and 62
Group 2) BPV-6 transmission calves - 53 and 59
BPV-5 Virus Preparation
The virus was purified from a pool of teat rice-grain 
fibropapillomas, which had previously been histologically 
screened and typed (Figure 12) . The lesions were obtained
from the Glasgow abattoir and stored in 50% PBS/Glycerol at
4°C until required for purification.
Teat rice-grain papillomas (1.74g) were homogenised in a 
Silverson grinder, using 17.4ml of 0.5% sodium deoxycholate 
and 0.5% NP40 as diluent. The suspension was clarified at
2,000 and 10,000 rpm for 10 minutes each. The supernatant was 
purified by rate zonal centrifugation as described on page 
33. The virus was visualised by TEM phosphotungstic acid 
negative staining and confirmed as positive with numerous 
particles present. A sample was also sent for restriction 
mapping and hybridization and was subsequently confirmed as 
containing only BPV-5 genome.
BPV-6 Virus Preparation
The virus was purified from a pool of teat frond squamous 
papillomas obtained from the Glasgow abattoir. These tumours 
were stored in 50% PBS/Glycerol at 4°C until required for 
purification.
Teat frond papillomas (15.57g) were homogenised in a 
Silverson grinder, using 60ml of 0.5% sodium deoxycholate and
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0.5-s NP40 as diluent. The suspension was clarified at 2,000 
and 10,000 rpm for 10 minutes each. The supernatant was 
purified by rate zonal centrifugation as described on page 
33. The virus was visualised by TEM phosphotungstic acid 
negative staining and confirmed as positive with numerous 
particles present. A sample was also sent for restriction 
mapping and hybridization and was subsequently confirmed as 
containing only BPV-6 genome.
BPV-5 and -6 Transmission Site
All 4 calves were anaesthetised with 3ml of Rompun (IM). The 
abdomen between the teats and the teats themselves were 
cleansed with ether prior to inoculation.
Each group of calves were deeply scarified on the teats and 
the adjacent skin of the udder with the aid of a needle and 
3ml of the type specific virus was run into the resultant 
groove.
The calves were bled for haematological analysis and serum 
sampling on a fortnightly basis and were clinically examined 
weekly.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun before surgically 
removing a representative piece of tissue for histological 
examination. All biopsy material was fixed in 10-6 BNF, 
followed by post fixation in corrosive formol. The material 
was then processed for embedding in paraffin wax. The 
sections were initially stained by H & E . Localisation of 
the viral antigen was carried out using type specific 
antisera in the PAP technique.
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Results of BPV-5 Transmission
In both calves 61 and 62 tumour development was first seen at 
26 weeks and was a raised, depilated line 2mm wide on the 
site of previous scarification. The biopsy showed a typical 
plaque like lesion with a marked epithelial thickening and a 
continuous keratinising edge with cytopathic changes in the 
nuclei. There was also well established plexiform acanthosis 
present but with no involvement of the sub-epithelial tissue. 
This is a BPV-5 lesion.
At 28 weeks the biopsy consisted of an epithelial plaque with 
no papillomatosis and no fibromatous component. There was an 
amplification of the granular layer with some evidence of 
viral inclusion bodies in the nuclei of the upper most cells 
of the granular layer.
By week 33 the biopsy was still basically a plaque like 
lesion with a thickened granular layer, large keratohyalin 
granules and cytopathology evident and widespread under the 
superficial keratin layer. There was still no fibromatous 
component and the lesion had an acanthotic base.
The biopsy at 37 weeks revealed a plaque lesion with a 
markedly thickened granular layer and plexiform acanthosis. 
There was however a mild degree of papillomatosis protruding 
from this plaque (Figure 13) .
When biopsied at 46 weeks the tumour was still an 
identifiable BPV-5 lesion. The base was acanthotic of a 
plexiform type and the granular layer was similar. On the 
outside edge of the tumour there was mild papillomatosis but 
the cytopathic changes were confined to the length of the 
sub-keratin layer. In this particular biopsy there was an 
adjacent fibroma. There was now evidence of a marked 
mononuclear reaction around the vascular spaces, which may
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have indicated the onset of the rejection process.
By 52 weeks the lesions are very similar to the previous 
biopsy. There were lymphoid and macrophage accumulations 
around the vascular spaces and at one edge of the lesion 
there was invasion and destruction of the basal cells by this 
mononuclear reaction.
Results of BPV-6 Transmission
Tumour development was first noted at 4 weeks as a raised 
epithelial plaque on the site of scarification. When examined 
by H & E, the lesion consisted of a small fibromatous nodule 
with the skin adnexal elements remaining. Overlying this sub- 
epithelial lesion was a slightly thickened squamous 
epithelium due to keratinocyte proliferation and there was 
also the first signs of rete-peg formation. There was no 
cytopathology and no viral antigen localised by 
immunocytochemistry.
By 6 weeks the fibroblast involvement in the sub-epithelial 
tissue was drastically reduced and replaced with collagen. 
There was a mild thickening of the epithelium along the 
length of the tumour due to keratinocyte proliferation. 
Keratohyalin granules were now evident in the sub-keratin 
layer and the areas of plexiform acanthosis were more 
established. No obvious cytopathology was seen nor was there 
any demonstrable viral antigen by the PAP technique.
At 10 weeks post infection, two thirds of the squamous 
epithelium was moderately thickened with a degree of 
parakeratosis. The plexiform acanthotic areas were well 
developed and definitive fronds formed. There were cytopathic 
cell changes in the sub-keratin layer but no viral antigen 
was localised by immunocytochemistry. In the sub-epithelial
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tissue a few lymphatic capillaries re-emerged.
The 18 week biopsy revealed a distinguishable papillomatous 
lesion. The squamous epithelium was markedly thickened and in 
the upper keratinocyte layer there were a number of 
cytopathic cells present. These cells were found to contain 
viral antigen by the PAP technique using type specific 
antisera. In the sub-epithelial tissue there was virtually a 
full return of the skin adnexal elements.
By the 23rd week the biopsy appeared as a well developed 
epithelial papilloma with cytopathic cells in association 
with large aggregates of keratohyalin granules in both the 
sub-keratin layer and the incorporation areas. Virus 
containing cells were localised in these areas, when examined 
by the PAP technique.
At 25 weeks the fronds of the papilloma were more numerous 
and elongated, (see Figure 14 for gross picture) . This was 
still a virally productive tumour.
The 29 week biopsy was a well developed epithelial papilloma 
with obvious cytopathology. Viral antigen was visualised in 
both the sub-keratin and incorporation zones by 
immunocytochemistry and electron microscopy.
The calves were observed for a further 6 months, with 
biopsies taken at monthly intervals. Only at 12 months did 
the lesions finally lose their viral antigen staining by the 
PAP technique.
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Figure 12: A BPV-5 papilloma from a field case showing the 
marked granular cell proliferation. H & E.
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Figure 13: An experimentally induced BPV-5 papilloma showing 
the marked proliferation of the granular layer. H & E.
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Figure 14: An experimentally induced BPV-6 papilloma on the 
teats and udder skin.
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Discussion
The objective of these experiments were to study the timing 
of the development of the stages of tumours induced by BPV-2, 
4, 5 and 6 and to verify that the lesion and site specificity 
for each virus corresponded to what had previously been found 
in naturally occurring outbreaks or had been demonstrated 
experimentally (Jarrett et al, 1985 ). As the main work of 
this thesis is concerned with immune protection and 
rejection, it was necessary to have a clear idea of the 
timing of the above phases.
In BPV-2 infections, the sequence was found to be as follows; 
Stage 1 in the development of the fibropapilloma was first 
recognised at 7 weeks after challenge. This lesion consisted 
of a fibroma with no thickening of the overlying epithelium 
and no expression of viral antigen. However 1 week later the 
lesions had shown marked signs of development. There was now 
thickening of the squamous epithelium and the establishment 
of plexiform acanthosis. There was no marked cytopathology 
but when examined by immunocytochemical techniques there was 
a small focus of cells expressing viral antigen. By 11 weeks 
the lesions were recognised as Stage 3 fibropapillomas with 
viral antigen in abundance in the upper granular layer of the 
epithelium. After this stage the animals differed 
dramatically; one calf (50), on histological examination, was 
obviously undergoing regression. This was apparent as there 
was no thickened epithelium, no plexiform acanthosis, no para 
-or hyperkeratosis and no viral antigen expressed. In the 
sub-epithelial tissue there was a massive proliferation of 
lymphocytes around the vessels and normal skin adnexal 
elements were also present. In contrast, calf 49 still 
appeared as a virally active fibropapilloma and it wasn't 
until 25 weeks after challenge that the first signs of 
regression were recognised; large infiltration of lymphocytes 
around the capillaries and the return of numerous hair
84
follicles. Although the lesion was undergoing regression, it 
was still a virally active one. The process of regression was 
a slow one and it was not until nearly a year after challenge 
that calf 49's skin returned to it's normal state.
In the BPV—4 transmission experiment, 2 weeks after the virus 
was injected, there were numerous, small, opalescent lesions 
seen in the mouth. By week 6 there was a fully formed 
epithelial papilloma, which had cells containing viral 
antigen, as demonstrated by the PAP technique. In the 
following weeks the papilloma did not change in structure but 
there was a significant increase in the overall size of the 
lesion and in the amount of viral antigen being expressed. 
However by week 21 the number of cells containing viral 
antigen diminished appreciably and was accompanied by a 
corresponding decrease in the positivity of the reaction. 
There was also a marked mitotic activity in the basal and 
parabasal layers. This stage remained constant until week 30, 
when no viral antigen was expressed. The epithelial 
papillomas remained on the palate, pharynx and oropharynx for 
more than 1 year but subsequent biopsies failed to detect any 
cells containing viral antigen.
In the BPV-5 infections, tumour development was first noted 
at 26 weeks after infection. This biopsy revealed a plaque 
like lesion with a marked epithelial thickening and 
cytopathic cells in the sub-keratin layer. This was an 
extremely slowly developing tumour and it was not until week 
37 that the classical rice grain' lesion was identified. 
However the biopsy taken at week 46 showed the first evidence 
of a sub-epithelial fibroma component. This might indicate 
that the fibromatous part occurs at a later stage of 
development of the BPV-5 lesion in contradistinction to that 
of BFV-1 and 2 where it occurs as the first stage. There was 
also a marked mononuclear reaction radiating from the 
perivascular spaces, which might indicate the first stage of
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a rejection reaction. By week 52 the basal cells had been 
invaded and in parts destroyed by accumulations of 
lymphocytes and macrophages. This rejection reaction had no 
obvious effect on the squamous epithelium. 
Immunohistochemical examination of these biopsies is not yet 
completed and therefore it is not possible to comment on the 
viral expression cycle at this moment.
In the experimentally induced BPV-6 infection, the first sign 
of tumour development was noted at 4 weeks after challenge. 
This biopsy revealed a plaque-like lesion consisting of a 
small fibromatous nodule with a slightly thickened overlying 
epithelium. There was no obvious cytopathology and no viral 
localisation. This lesion continued to develop but at a slow 
rate and it was not until week 18 that a fully developed 
papilloma was seen. There were cytopathic cells in the upper 
keratinocyte layer and these were confirmed to be virus- 
containing cells when examined by the PAP technique and by 
transmission electron microscopy. In subsequent biopsies over 
8 months, virus-containing cells were demonstrated by the PAP 
technique using type specific antiserum. Only after 12 
months did the lesions finally lose their viral antigen 
staining, when examined immunologically.
From the transmission experiments, the nature and the timing 
of the developmental stages have been found. The periods 
when active viral replication is taking place have been 
defined. With the technology described in chapter 2, it is 
now very simple and quick to determine the type of virus 
causing an infection, which would be beneficial to clinicians 
and scientists if any therapeutic regimes were to be 
considered in the future. These experiments allow the 
diagnosis of tumours caused by the different viruses and 
indicate the times at which virus production is present and 
maximal. This is valuable in choosing source material for any 
given virus isolation. From the above data it is imperative
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to determine as far as possible the stage and age of the 
lesion. This is necessary if virus purification is to be 
undertaken, as there is no value in taking old, well 
established lesions because they are not prolifigate in 
virus.
87
Introduction
BPV-4 is the causative agent of papillomatosis of the upper 
alimentary canal in cattle (Jarrett et al, 1978). Some of 
these papillomas may progress to cancer (Jarrett, 1981) in 
animals which are exposed to continuous ingestion of bracken 
fern and are chronically immunosuppressed (Jarrett et al, 
1978b).
One of the main reasons for carrying out this series of 
experiments was to re-investigate the whole status of 
immunity to bovine papillomavirus infections, since it became 
obvious that different types and subgroups existed. It was 
apparent that many anomalies in the past such as the 
irregular success of crude vaccines could be due to antigenic 
heterogeneity. The experiments were therefore designed to 
examine the status of a papillomavirus infection and 
reinfection among different virus types.
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CHAPTER 4
REINFECTION OF TUMOUR CALVES WITH BOVINE PAPILLOMAVIRUS
TYPE-4
Experiment 4
BFV-4 Reinfection of BPV-2 Infected Calves
Two calves (49 & 50) from the previous BPV-2 cell membrane 
prophylactic vaccine experiment were used. These had been 
through a full cycle of BPV-2 induced fibropapilloma and the 
susceptibility of these animals to an infection from a 
different sub-group, BFV-4 was investigated.
Material and Methods
BPV-4 Virus Challenge Preparation
The virus for this transmission experiment was purified from 
a pool of oesophageal epithelial papillomas, which are 
associated with BPV-4. These tumours were obtained from the 
Glasgow abattoir and were stored in 50% PBS/Glycerol at 4°C 
until required for purification.
Oesophageal papillomas (8.3g) were homogenised in a Silverson 
grinder, using 41.5ml of 0.5% sodium deoxycholate and 0.5% 
NP40 as diluent. The suspension was clarified at 2,000 and
10,000 rpm for 10 minutes each. The supernatant was purified 
by rate zonal centrifugation as described on page 33 and the 
resultant virus was examined by TEM phosphotungstic acid 
negative staining, which confirmed the presence of numerous 
particles.
BPV-4 Challenge Site
The two calves were anaesthetised with 3ml Rompun (IM) and 
immediately before injection of the virus 2ml of Brietal 
Sodium (Lilly) was given intravenously (IV) . 3ml of the
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purified BPV-4 virus was given by numerous intra-dermal 
inoculations into the soft and hard palate. At fortnightly 
intervals the calves were clinically examined and bled for 
both haematological analysis and serum sampling.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun and Brietal before 
surgically removing a lesion with the aid of a 3mm biopsy 
punch. The biopsy material was fixed in 10% BNF followed by 
post fixation in corrosive formol. The material was then 
processed for embedding in paraffin wax. The sections were 
initially stained by H & E. Immunocytochemical localisation 
of the viral antigen was demonstrated by the PAP technique 
using type specific antisera.
Results
Calves 49 and 50 mouths were examined 2 weeks after injection
and there was no obvious lesions seen.
The first obvious lesions were noted at 4 weeks post 
injection where both calves had distinct tumours present over 
the inoculation sites on the palate. These lesions were 
slightly raised, white, projectile plaques 1 to 2mm in
diameter. Histologically the biopsy contained a small 
developing tubule which would ultimately form a papilloma but 
there was no evidence of a papilloma present. There was a 
marked mitotic activity of the basal and parabasal cells. No 
parakeratosis or dyskeratosis present in this lesion. When 
examined by the PAP technique, using antisera raised to
disrupted BPV-4 virions, there was no evidence of a viral 
infection.
The 6 week examination revealed more than 30 small, white
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papillomatous like lesions projecting 2mm from the palate. No 
biopsy was taken.
Both calves were examined at 8 weeks, when it was decided to 
destroy calf 50 a) to obtain early stage lesions for 
immunocytochemical studies and b) to obtain early transformed 
cells in an attempt to grow in tissue culture. There were >25 
palatine lesions which were 1 to 2mm raised, white plaques, 
the most protuberant being 1mm high. Histologically they were 
plaque like lesions with varying degrees of epithelial 
thickening. Most exhibited a marked mitotic activity and 
thickening of the basal and parabasal layers but the cells 
could not be differentiated. There was a slight frond 
formation at this stage and parakeratosis was present. The 
PAP technique, using rabbit anti-split BPV-4 antisera, 
demonstrated a significant number of cells containing viral 
antigen. This was localised in the sub-keratin layer.
At 10 weeks calf 49 had numerous true papillomas covering the 
palate and one was biops ied. Microscopically this was 
confirmed as a well developed epithelial papilloma. Overlying 
the fronds and in the incorporation areas there was 
parakeratosis. The cells within these areas had obvious 
cytopathic changes and inclusion bodies were easily 
identified in the H & E section. Viral antigen was found in 
abundance, by the PAP technique, at the keratinocyte keratin 
junction and in the incorporation areas.
At 18 weeks there were still present numerous well developed 
papillomas at the sites of injection. Histologically the 
papillomas were well developed and fully fronded in 
appearance. The fronds were longer and had keratinised tips 
and there were marked incorporation zones present with 
evidence of parakeratosis at these points as well as 
overlying the fronds. Large numbers of virus containing cells 
were present in the sub-keratin layer and the incorporation
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areas. This was confirmed by the PAP technique.
After 37 weeks post injection, the papillomas had not 
diminished in numbers but were smaller and broader in size. 
They still retained their filliform structure and were 
apparently not spreading to the adjacent non-injection sites. 
Microscopically it was a well developed papilloma but with a 
marked hyperkeratosis present. The keratinocytes and the 
basal and parabasal cells appeared not as active as in 
previous biopsies. Immunocytochemically there was virtually a 
negative reaction. There were cytopathic cells, which were 
degenerating and had a speckled positivity confirming a 
previous viral infection.
This calf was monitored at monthly intervals and at the 59th 
week there was still present a few blunted, filliform 
papillomas.
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Experiment 5
BPV-4 Reinfection of BPV-5 and BPV-6 Infected Cattle
Using the calves from previous BPV-5 and BPV-6 transmission 
experiments, which had successfully completed the tumour 
cycle, it was decided to observe the susceptibility of these 
animals to a BPV-4 infection.
Material and Methods
BPV-4 Virus Challenge Preparation
The virus for this transmission experiment was purified from 
a pool of oesophageal epithelial papillomas, which are 
associated with BPV-4. These tumours were obtained from the 
Glasgow abattoir and were stored in 50% PBS/Glycerol at 4°C 
until required for purification.
BPV-4 tumours (5g) from a pooled source were homogenised in a 
Silverson grinder, using 25ml of 0.5% sodium deoxycholate and 
0.5% NP40 as diluent. The suspension was clarified at 2,000 
and 10,000 rpm for 10 minutes each. The supernatant was 
purified by rate zonal centrifugation as described in chapter 
2 and the resultant virus was visualised by TEM 
phosphotungstic acid negative staining. This confirmed the 
presence of numerous viral particles.
BPV-4 Challenge Site
All animals were anaesthetised with 3ml of Rompun (IM) and 
immediately before injection of the virus 2ml of Brietal 
Sodium was given IV. 3.5ml of the purified BPV-4 virus was 
given by numerous intra—dermal inoculations into the soft and
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hard palate. At fortnightly intervals the calves were 
clinically examined and bled for both haematological analysis 
and serum sampling.
Results
The four calves (53, 54, 55 & 56) were subjected to a mouth 
examination 4 weeks after the injection of BPV-4 into the 
palate.
Calves 53 & 54, which had previously undergone a tumour cycle 
induced by BPV-6, had numerous small, translucent plaque like 
lesions on the palate. There was also two small well formed 
papillomas. Calves 55 & 56, which had previously undergone a 
tumour cycle induced by BPV-5 and had a secondary spread of 
BPV-1 induced lesions, had clusters of small, refractile 
tumours on the palate as well as one papillomatous-like 
lesion.
As the previous reinfection experimental calves were 
subjected to detailed histological examination by surgical 
biopsying of the developing tumours, it was decided to 
clinically examine these animals to avoid unnecessary trauma.
At 6 weeks post infection all four calves had >20 small, 
projectile lesions on the palate as well as the odd one or 
two frond papillomas.
By 8 weeks, the 20 or more lesions were typical squamous 
papillomas albeit small in projection.
After the 8 week examination the calves mouths were 
clinically examined at monthly intervals.
The 31 week mouth examination showed that all the calves had
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masses of well developed papillomas on the palate at the 
sites of injection. Microscopically they were well developed 
papillomas, with numerous fronds and a marked hyperkeratosis 
present. There were large numbers of virus containing cells 
in both the incorporation zones and the sub-keratin layer. 
The PAP technique confirmed the presence of type specific 
viral antigen in these sites and that the cells were heavily 
laden.
The final mouth examination was carried out at 40 weeks and 
the mass of epithelial papillomas were still present on the 
palate. Many of the individual papillomas were merged 
together to form a solid plaque.
Discussion
As stated earlier, it was of major importance to establish 
whether the immune and protective phenomena were induced by 
group or type specific antigens and whether there was any 
degree of cross-immunity between types within a species. The 
object of the above experiments were to answer these 
questions. The animals selected had all completed the cycles 
of oncogenesis from infection to rejection for BPV-1, 2, 5 &
6.
From the above data, all the calves developed lesions within 
the first 4 weeks of the virus application. These were
slightly raised, white, projectile lesions found over the 
inoculation sites. At this stage there were no cells 
containing viral antigen. By 8 weeks there were numerous, 
small papillomas on the palate. There were a significant
number of cells containing viral antigen as demonstrated by 
the PAP technique. These calves were examined at regular
intervals over 1 year and still had papillomas present in
their mouths. Positive staining of the viral antigen by
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immunocytochemistry was not seen after the 40th week.
These two experiments show that infection with one type of 
BPV does not confer protective immunity against .another type.
INffi¥K#foNs
Prophylactic and Therapeutic Treatments for Papillomavirus 
Infections
Papillomavirus infections are common in cattle but they still 
pose difficult therapeutic problems because of their 
persistent and recurrent nature. This subsequently results in 
serious reproductive as well as economic problems. There are 
numerous clinical treatments for human cutaneous or mucosal 
papillomas (Rees, 1985; Leventhal et al, 1985), which 
include surgical removal (incorporating CO2 laser and 
cryosurgery), chemotherapy (using podophyllin, bleomycin 
etc.), antiviral agents (interferons etc.) and immunotherapy 
(eg. vaccines).
Surgery is frequently required in patients with laryngeal 
papillomatosis, possibly every few weeks, to allow an open 
airway but the chances of remission with this technique are 
relatively low (Steinberg et al, 1987) . It has been shown 
that podophyllin may have significant toxicity and malignancy 
risks when used as a therapeutic agent (Stoehr et al, 1978; 
Chamberlin et al, 1972) . However recent data in the review 
by Week and Whisnant (1987) is giving hope in the use of 
interferon with its antiviral and antiproliferative effects. 
This therapeutic agent has consistently shown in major 
clinical trials its ability to induce regression and 
effective control of HFV infections of the respiratory tract, 
genitalia and the skin, but not without side effects. 
Although some studies using autologous vaccines have reported 
a high success rate, there is no direct evidence that the 
responses are specific for HFV antigens as Malison et al, 
(1982) showed that a vaccine prepared from warts was not 
significantly different from one prepared from the patients 
skin. Therefore further studies are required to determine the 
function of FV proteins, which may determine the 
identification of common, protective antigenic determinants.
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All the above treatments have had initial success but there 
is no evidence of a sustained effective therapy due to the 
high recurrence rate. It is also evident that the current 
therapeutic regimes do not selectively inhibit the viral 
process but only destroy the infected epithelial cells.
Cattle provide us with an excellent animal model system for 
papillomavirus infections in humans, as several 
manifestations are common in the two systems; multiple virus 
types, specificity of lesions, malignant progression of some 
papillomas and the involvement of cofactors.
With these considerations it was decided, using cattle as a 
model system, to develop and examine the efficacy of 
prophylactic immunisation regimes using i) purified membranes 
from transformed bovine cells; ii) purified virus; iii) 
papillomatous tumour extracts.
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Vaccination Procedures Against PV Infections in Cattle
Experiment 6
Prophylactic Vaccination Studies of Cattle Using In Vitro 
Transformed Bovine Cells
It has been established that BPV's contain all of the genetic 
information necessary for the transformation of bovine 
fibroblasts in vitro (Jarrett et al, 1988 in press) . It was 
therefore a natural progression to ascertain the efficacy of 
membrane preparations from BPV transformed bovine cells as 
immunogens.
An experiment was designed, using 4 calves, in a pilot study 
to determine the feasibility of using bovine cells grown in a 
tissue culture system as a protective agent in BPV 
infections.
Material and Methods
Calves
The four calves were purchased from a reputable dealer who 
previously examined both the calf and the dam to ensure there 
was no evidence of a papillomavirus infection. The calves 
were all 12 week old, male, Ayrshire cross and on arrival 
were immediately housed in the isolation unit. This 
experiment consisted of 2 vaccinates and 2 non-vaccinates 
(controls) and these were housed in separate isolation pens. 
They were then bled for both haematological analysis and for 
serum, the latter being stored at -20°C for future studies. 
Three weeks later, when the calves were 15 weeks of age the
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experiment was initiated.
Group 1) Cell membrane vaccine calves - 49 & 50
Group 2) Vaccine controls - 51 & 52
BPV—2 Cell Membrane Vaccine
This was an established bovine conjunctival cell line which 
had been transformed with BPV-2 and was termed 16CON/BCPV-16. 
This procedure was carried out by a colleague Dr B. Watt.
The conjunctiva was obtained from a late term foetus and was
cut up finely with scissors before being subjected to 
trypsinisation. The cells were then plated on a 25mm plastic 
petri dish at a density of 5 x 105 cells per plate. 0.5ml of 
bovine cutaneous papillomavirus (BCPV) C16 at 1/50 dilution 
(for purification see isopycnic centrifugation in chapter 2) 
was added to each plate along with 2ml of Dulbecco's Minimum 
Essential Medium (MEM) containing 10% foetal bovine serum 
(FBS) and incubated overnight at 37°C. The cultures were then 
washed three times with fresh medium and incubated at 37°C. 
After 24 hours the cells were given another wash with medium 
containing FBS. The cultures were split when they were 
confluent, which was approximately twice a week and 
transformation assessed. These particular cells were stored 
in liquid nitrogen at passage 20 until they were required. 
The cells were thawed and washed 3 times in serum free MEM 
before a viability count was established. They were then 
resuspended in 2 x 2ml aliquots containing 2.45 x 107 cells 
per aliquot.
Vaccine Site
The two vaccinate calves, 49 and 50 were injected with 1ml of 
transformed cells into the left quadriceps muscle and 1ml of 
transformed cells plus 1ml of Alhydrogel (aluminium
100
hydroxide) adjuvant into the right quadricep muscle. This 
procedure was repeated 14 days later.
BPV-2 Vaccine Challenge
Virus was purified from a fully developed cutaneous 
fibropapilloma of the upper body of a cow (76119/10) as 
described on page 33, using rate zonal centrifugation. A 
sample of the resultant virus was sent to Dr S. Campo for 
restriction mapping and hybridization and was subsequently 
confirmed as containing only BPV-2 genome. A sample of virus 
was also sent to Dr H. Laird for quantitative estimation by 
TEM using phosphotungstic acid negative staining. The virus 
content was estimated to be approximately 1012 particles per 
ml. This calculation is based on comparing protein 
estimations, a method prolifigate in virus wastage and 
haemagglutination, that when 1 or 2 particles are found per 
grid square in a neat virus preparation, this represents 
approximately 109 particles per ml. This virus, with 6 grids
_ o
for each dilution, still had particles m  the 10 dilution 
thus giving a total of 1012 particles per ml.
BPV-2 Challenge Site on Vaccinated Calves
Three weeks after the last vaccine injection the animals were 
anaesthetised using 3ml of Rompun (Bayer) intramuscularly 
(IM) , before shaving the left side of the neck. The skin was 
then cleansed with ether before 3 x 4  inch vertical 
scarification lines were made with the aid of a scarification 
needle. The depth of the wound is important, as discussed in 
the literature review, and it was found to be necessary to 
draw blood when scarifying. Into the resultant grooves was 
run the neat virus.
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Control Calves
The two control calves 51 and 52, were challenged with the 
same virus preparation and at the same time as the vaccinated 
calves, but the site and mode were varied as described below.
BPV-2 Challenge Site on Control Calves
The animals were anaesthetised as described for the 
vaccinated calves. Both sides of their necks were shaved and 
treated with ether immediately before inoculation. On the 
right side of the neck 3 x 4  inch vertical scarification 
lines were made and the technique followed as described for 
the vaccinated calves. However, on the left side of the neck 
a grid pattern was drawn on the shaved patch with 5 
replicates of dilutions, ranging from 10-1 to 10-6 of the 
same virus. The virus was diluted in TBS. On the caudal side 
of the grid, 5 "neat" intradermal inoculations of 0.1ml 
purified BPV-2 virus was given, followed by the series of 
virus dilutions, again by intradermal inoculation.
The calves were examined weekly with regular bleeding on a 
fortnightly basis.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun before surgically 
removing a small representative piece of tissue for 
histological examination. All biopsy material was fixed in 
10% BNF followed by post fixation in corrosive formol. The 
material was then processed for embedding in paraffin wax. 
The sections were initially stained by H & E. Immunological 
studies were carried out where applicable by the PAP 
technique using the "split" BPV-2 antisera.
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Results
Tumour development was first noticed at 7 weeks post 
challenge in both the unvaccinated and the vaccinated calves. 
This was seen as a smooth surfaced, fibromatous like lesion 
on the site of scarification. Histologically this was 
confirmed as a Stage 1 fibropapilloma with no evidence of 
replicating virus present.
(A detailed histological description of all the biopsy 
material in this experiment is given in chapter 3) .
By 8 weeks these lesions had developed into a Stage 2 
fibro-papillomas and again no viral antigen could be detected 
by the PAP technique.
At 11 weeks on both the vaccinated and unvaccinated calves, 
prominent, depilated and markedly papillomatous lesions were 
seen on the site of previous scarification. Histologically, 
the tumour was a Stage 3, well developed fibropapilloma with 
a marked thickening of the keratinocyte layer and showing a 
degree of plexiform acanthosis. In the upper keratinocyte 
layer there was cytopathic changes present and when examined 
by immunocytochemistry (PAP) the presence of nuclei 
containing virus was confirmed.
The calves were examined for a further 7 months during which 
regular biopsies were taken for histological examination. The 
biopsy at 25 weeks still showed a virally productive 
fibropapilloma but by the 35th week although there was still 
present a confluent line of typical fibropapillomas, no viral 
antigen could be demonstrated. Histologically it appeared as 
a hyperkeratotic lesion with no fibromatous component. The 
last biopsy was taken on the 40th week and the lesions were 
hyperkeratotic and easily broken off.
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Experiment 7
Comparison of Prophylactic Vaccination Studies in Cattle 
Between BPV—2 Tumour Suspension and Purified Virions
BPV-2 is associated with cutaneous fibropapilloma found on 
all parts of the body but mainly on the forehead, neck, upper 
thorax and back. These infections can last for anything up to 
one year before spontaneously regressing but occasionally 
some animals are unable to reject the infection and are 
destroyed because of the widespread involvement of these 
lesions.
This experiment was designed to test and compare the efficacy 
of specific tumour suspension and purified virions, to induce 
rejection of a papillomavirus infection.
Material and Methods
Calves
Nine calves were purchased from the same source as the 
previous experiment and were examined along with the dam for 
any evidence of a papillomavirus infection. The calves were 
10 week old, male, Friesians and on arrival were randomly 
selected into three groups, which were housed in separate, 
clean, well ventilated pens in the isolation unit. The 
experiment was designed as follows;
Group 1) BPV-2 Tumour vaccine calves - No's 64, 65 & 66
Group 2) BPV-2 Virus vaccine calves - No's 69, 70 & 71
Group 3) Vaccine control calves - No's 74, 75 & 76
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All were bled on arrival for both haematological analysis and 
for serum sampling, which was labelled and stored at -20°C 
for future studies. Six weeks later, when the calves were 16 
weeks of age the experiment was initiated.
BPV—2 Tumour and Virus Vaccine Preparation
Both BPV-2 tumour cells and virions were obtained from a 
fully developed cutaneous fibropapilloma of the upper body of 
a cow (76119/12) , which had been previously confirmed by 
restriction mapping and hybridization as containing only BFV- 
2 genome. Viral content and quantitation was confirmed by 
phosphotungstic acid negative staining on the TEM. The virus 
content was estimated to be approximately 1012 particles per 
ml.
BPV-2 Tumour Extract Preparation
24g of diced cutaneous papilloma epithelium (76119/12) was 
homogenised in a Silverson grinder for 20 minutes at 4°C, 
using 48ml of Tris buffer as diluent. The material was 
divided into two equal amounts ie. 37ml each. The tumour cell 
extract was made up to 65ml with Tris buffer, mixed well and 
then aliquoted into 6 x 10ml, each therefore containing 
approximately 2gm equivalent of BPV-2 tumour. 3 x 10ml 
aliquots were stored at -70°C for use in the second 
inoculation.
BPV-2 Virus Preparation
The 37ml from the tumour extract preparation was spun at 
2,OOOrpm
for 5 minutes and the supernatant stored at 4°C. The cellular 
debris was further homogenised using 29ml of 0.5% sodium 
deoxycholate and 0.5% NP40. When the homogenising was
complete the original stored supernatant was added to the
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homogenate and thoroughly mixed. The material was then 
purified as described on page33by rate zonal centrifugation. 
There was 27ml of virus realised. After dialysis the virus 
was concentrated to 20ml with Carbowax and then aliquoted 
into 6 x 3ml amounts, each containing approximately 2gm 
equivalent of tumour virus. 3 x 3ml aliquots were stored at - 
70°C for use in the second inoculation.
Vaccine Sites
The three tumour cell vaccinate calves, 64, 65 and 66 were 
injected with 10ml of tumour suspension deep into the right
and left quadricep muscles. The booster was given 21 days
later by the same material and by the same procedure.
The three virus vaccinate calves, 69, 70 and 71 were injected 
with 3ml of purified BPV-2 virions into the right quadricep 
muscle. The booster was given 21 days later with the same 
material and by the same procedure.
BPV-2 Vaccine Challenge
The virus was purified from the same source as the vaccines 
ie bovine cutaneous fibropapilloma (76119/12); confirmed by 
restriction mapping and hybridization as BPV-2 only. 7gms of 
76119/12 was homogenised using 35ml of 0.5% sodium
deoxycholate & 0.5% NP40 as diluent. The virus was purified 
as described on page 33 by rate zonal centrifugation. 10ml of 
purified BPV-2 was obtained and this was used for the
challenge on the vaccinated calves as well as the control 
calves.
BPV-2 Challenge Site for Vaccinated and Control Calves 
Three weeks after the last vaccine injection all the animals
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were anaesthetised using 3ml of Rompun (IM), before shaving a 
patch on the right side of the neck. The skin was then 
cleansed with ether before 4 x 4  inch vertical scarification 
lines were made with the aid of a scarification needle. 1ml 
of purified BPV-2 virus was run into the resultant groove. 
The calves were examined and bled for haematological analysis 
and serum sampling on a two weekly basis.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun before surgically 
removing a small representative piece of tissue for 
histological examination. All biopsy material was fixed in 
10% BNF followed by post fixation in corrosive formol. The 
material was then processed for embedding in paraffin wax. 
The sections were initially stained by H & E. Immunological 
studies were carried out using cross-reactive antisera in the 
PAP technique.
Results
At 4 weeks, tumour development was first recorded in the 
unvaccinated group (74, 75 & 76). This was a small, raised, 
fibromatous like lesion. These lesions developed until the 
6th week, when they were seen as typical cutaneous 
fibropapillomas.
By the 9th week post infection, all animals were clinically 
examined. In the virus vaccination group, only calf 70 had a 
slight thickening of the epithelium in one of the lines of 
scarification. Histologically, there was no thickening of the 
squamous epithelium but underlying there was a small 
fibromatous nodule. There was no cytopathology and when 
examined by the PAP technique there was no viral antigen
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expressed.
Calf 65 in the tumour vaccination group was the only calf to 
have
any visible lesions. It had a few, smooth surfaced nodules on 
one line of scarification. On examination by H & E the lesion 
was very similar to the biopsy in calf 70. Again there was no 
viral antigen detected by the PAP technique.
All the unvaccinated calves (74, 75 & 76) had prominent and 
markedly papillomatous lesions on all the lines of 
scarification. The tumours were depilated and hyperkeratotic. 
Histologically the tumour was a well developed, 
hyperkeratotic fibropapilloma with a marked plexiform 
acanthosis. There was no remaining adnexal elements. The 
keratinocyte layer was markedly thickened and in the upper 
layer there was numerous cytopathic cells surrounded and 
partially masked by highly irregular and dense keratohyalin 
granules. The viral antigen was positively located in this 
area by the PAP technique.
When examined at 14 weeks calf 70 of the virus vaccine group 
had no lesions on the scarification sites and the former 
biopsy site had completely healed. Calves 69 and 71 still had 
no lesions on the sites of scarification.
In the tumour vaccine group, calf 65 still had obvious 
lesions on one of the scarification lines. There were 4 
flattened, 12 x 10 mm, fibromatous like lesions with very 
little overlying keratin. Histologically, it was a Stage 1 
fibropapilloma. The lesion had a slight thickening of the 
keratinocyte layer in one small area which slightly 
penetrated into the fibromatous tissue. Overlying a small 
area of the fibromatous component was an ulcerated 
epithelium. There was some evidence of cytopathic changes but 
there was no virus visualised in the cell nuclei by the PAP
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technique. Calves 64 and 66 had no lesions on the sites of 
scarification.
The unvaccinated group (74, 75 & 76) had numerous,
depilated, hyperkeratotic fibropapillomas on all lines of 
scarification. Microscopically, they were well developed, 
hyperkeratotic fibropapillomas with a marked plexiform 
acanthosis. Cytopathic changes were still evident and virus 
containing cell nuclei were positively demonstrated in the 
upper granular layer by the PAP technique.
At 18 weeks post infection calf 65 from the tumour vaccine 
group still had 4 fibromatous lesions. Whereas in previous 
examinations these lesions were of single entities they had 
now merged together to form a linear lesion. Histologically, 
this was a Stage 2 fibropapilloma. It still had slight 
thickening of the epithelium but had a more obvious plexiform 
acanthotic form. There was still an area of ulcerated 
epithelium present. Again some evidence of cytopathic changes 
but no replicating virus could be demonstrated by the PAP 
technique. This calf was examined finally at the 29th week 
and there was no epithelial lesions or thickening visible.
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Experiment 8
Prophylactic Vaccination Studies in Cattle Using Purified 
BPV—4 Virions as the Immunogen
BPV—4 is associated with alimentary squamous papillomas in 
cattle and is a member of subgroup B of the BPV's. This 
group, which includes BPV-3, 4 and 6 transform only squamous 
epithelial cells. These frond type warts are purely 
epithelial lesions and were found in 20% of cattle usually as 
a single tumour. However some animals were found to have 
several hundred papillomas in the mouth, tongue, pharynx and 
oesophagus. These animals were ultimately destroyed due to 
their severe clinical disease. Under experimental conditions 
the course of a primary infection lasts approximately 12 
months.
Another very interesting finding was the presence of upper 
alimentary carcinomas at the same sites as these squamous 
papillomas. The relationship, if any, between this virus 
induced papilloma and the carcinoma is still not resolved.
This experiment was designed to test the efficacy of specific 
tumour virions to protect cattle against a homologous 
papillomavirus infection.
Material and Methods 
Calves
Four calves were purchased from the same source as the 
previous experiments to ensure that the calves were not in 
contact with animals which might have a papillomavirus
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infection. The calves were 10 week old, male, Friesians and 
on arrival were randomly selected into 2 groups, which were 
then housed in separate, clean, well ventilated pens in the 
isolation unit. This experiment consisted of 2 vaccinates and 
2 non-vaccinates (controls). The calves were bled on arrival
for both haematological analysis and for serum, the latter 
being stored at -20°C for future studies. Six weeks later, 
when the calves were 16 weeks of age the experiment was
initiated.
Group 1) BPV-4 virus vaccine calves - 115 & 116 
Group 2) BPV-4 vaccine control calves - 117 & 118
BPV-4 Virus Vaccine and Challenge Preparation
Both the virus vaccine and the challenge preparation were
purified from a single case of bovine oesophageal 
papillomatosis, which as stated earlier associated with 
BPV-4. These tumours were obtained from the Glasgow abattoir, 
which is a large automated and modern slaughterhouse. The
oesophaguses were examined and selection was based on single 
cases where there were numerous epithelial papillomas 
present. These tumours were stored in 50% PBS/Glycerol at 4°C 
until required for purification.
BPV-4 tumours (20g) from a single case were homogenised in a 
Silverson grinder, using 60ml of PBS as diluent. The 
suspension was clarified at 2,000 and 10,000 rpm for 10 
minutes each. The supernatant was aliquoted into 2gm 
equivalents ie 6.6ml. To estimate viral content, 6.6ml of the 
supernatant was purified by rate zonal centrifugation as 
described in chapter 2 and the resultant virus visualised by 
TEM phosphotungstic acid negative staining. The virus content 
was estimated to be approximately 1012 particles per ml. The 
doses for the vaccine animals were aliquoted into 4 x 6.6mls.
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The virus for the challenge dose was aliquoted in to 4 x lml.
BPV-4 Vaccine Sites
The two prophylactic vaccine calves, 115 and 116 were 
injected with 6.6ml of the clarified viral suspension plus 
6.6ml of Freund's complete adjuvant. After 14 days had 
elapsed another injection of 6.6ml of virus plus 6.6ml of 
Freund's incomplete adjuvant was administered. Both 
injections were given in equal volumes to the right and left 
quadricep muscles.
BPV-4 Challenge Site for Vaccinated and Control Calves
Two weeks after the last vaccine injection all the animals 
were anaesthetised with 3ml of Rompun (IM) and immediately 
before injection of the virus, 2ml of Brietal Sodium was 
given (IV) . lml of the purified BPV-4 virus was inoculated 
into the soft and hard palate by approximately 20 intra- 
dermal injections. At fortnightly intervals the calves were 
examined in detail and bled for both haematological analysis 
and serum sampling.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun and Brietal before 
surgically removing a lesion with the aid of a 3mm biopsy 
punch. The biopsy was fixed in 10% BNF followed by post 
fixation in corrosive formol. The material was then processed 
for embedding in paraffin wax. The sections were initially 
stained by H & E. Immunocytochemical localisation of the 
viral antigen was demonstrated by the PAP technique using 
type specific antisera.
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Results
At 4 weeks post infection, the unvaccinated calves(117 & 118) 
had numerous small, white, projectile lesions on the palate. 
Histologically they were plaque like lesions with epithelial 
thickening due to the proliferation of the basal and 
parabasal cells. There was also parakeratosis present 
overlying the epithelium. In a small area of the biopsy there 
was evidence of a slight projection, which in the future 
would have developed into a frond. Cytopathic changes were 
evident in the sub-keratin layer. The PAP technique, using 
type-specific antisera, located positive cells in the 
incorporation areas confirming the presence of a virus- 
induced tumour.
The vaccinated calves (115 & 116) had no visible lesions in 
the mouth.
By 6 weeks both unvaccinated calves had numerous true 
papillomas covering the palate. Immunocytochemically the 
viral antigen was demonstrated in many cells, both in the 
sub-keratin layer and the incorporation areas. These cells 
were heavily stained. Again the vaccinated calves showed no 
evidence of a papilloma infection.
The calves were observed for a further 3 months and biopsies 
were taken at 8, 10, 12 & 17 weeks post injection for
histological and immunocytochemical examination.
Histologically, they were all true epithelial papillomas of 
the alimentary tract and the viral antigen was 
immunologically positive by the PAP technique throughout the 
duration of the experiment.
Throughout this experiment there were no lesions seen in the 
mouths of the vaccinated calves.
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Experiment 9
Prophylactic Vaccination Studies of Cattle Using BPV-6 
Virions as the Immunogen
BPV-6 is the virus associated with the frond epithelial 
papilloma on the skin of the teats and udder of cattle. It is 
a common infection in both beef and dairy cattle where it 
often occurs in association with lesions produced by BPV-1 
and 5 (Lindholm et al, 1984) . Although BPV-6 induced tumours
are the most common of the paragenital lesions, it also 
presents itself as a serious clinical problem. A severe 
infection can easily spread throughout a herd of cattle 
resulting in interference with milking or secondary 
infections of the teats, both of which can cause serious 
economic problems.
This experiment was designed to test the efficacy of specific 
tumour virions to protect against a homologous papillomavirus 
infection.
Material and Methods 
Calves
Six calves were purchased from the same source as the 
previous experiments. These calves were not in contact with 
other animals and were selected as being free of any obvious 
papillomavirus infection by clinical examination. The calves 
were 10 week old, male, Friesians and on arrival were 
randomly selected into 2 groups, which were then housed in 
separate, clean, well ventilated pens in the isolation unit. 
This experiment consisted of 3 vaccinates and 3 non—
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vaccinates (controls) The calves were bled on arrival for 
both haematological analysis and serum sampling, which was 
stored at -20°C for future studies. The experiment was 
initiated when the calves were 20 weeks old.
Group 1) BPV-6 virus vaccine calves - 101, 103 & 105
Group 2) BPV-6 vaccine control calves - 102, 104 & 108
BPV-6 Virus Vaccine Preparation
Both the virus vaccine and the challenge preparation were 
purified from a pool of teat frond papillomas obtained from 
the Glasgow abattoir. These tumours were stored in 50%
PBS/Glycerol at 4°C until required for purification.
Teat frond papillomas (19g) were diced by scissors and
homogenised in a Silverson grinder using 95ml of 0.5% sodium 
deoxycholate and 0.5% NP40 as diluent. The suspension was
clarified at 2,000 and 10,000 rpm for 10 minutes each. The
supernatant was purified by rate zonal purification as 
described on page 33 and the resultant virus was quantified 
by TEM phosphotungstic acid negative staining. The virus 
content was estimated to be approximately 1011 particles per 
ml. A sample was also sent for restriction mapping and 
hybridization and was subsequently confirmed as containing 
only BPV-6 genome.
Vaccine Sites
The three prophylactic vaccine calves, 101, 103 and 105 were 
injected with 1.5ml of purified BPV-6 virions plus 1.5ml of 
FI A. After 14 days had elapsed another injection of the same 
preparation was administered. Both injections were given in 
equal volumes to the right and left quadricep muscles.
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BPV—6 Challenge Preparation
A similar preparation to the BPV-6 virus vaccine was made 
using 9.5g of pooled teat frond papillomas and 45ml of 
diluent. The same procedures and checks were made as 
described above.
BPV-6 Challenge Site for Vaccinated and Control Calves
Two weeks after the last vaccine injection all the animals 
were anaesthetised using 3ml of Rompun (IM) . The abdomen 
between the teats was cleansed with ether before a linear 
scarification line was made with the aid of a scarification 
needle to the skin between the anterior and posterior teats 
on the left side, lml of purified BPV-6 virus was run into 
the resultant groove. The calves were bled for haematological 
analysis and serum sampling on a fortnightly basis and were 
clinically examined weekly.
Surgical and Histological Procedures
The calves were anaesthetised with Rompun before surgically 
removing a small representative piece of tissue for 
histological examination. The biopsy was fixed in 10% BNF 
followed by post fixation in corrosive formol. The material 
was then processed for embedding in paraffin wax. The 
sections were initially stained by H & E. Immunocytochemical 
localisation of the viral antigen was demonstrated by the PAP 
technique using type specific antisera.
Results
At 10 weeks on the unvaccinated calves (102, 104 & 108),
raised epithelial plaques were seen on the site of previous
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scarification. The vaccinated calves (101, 103 & 105) had no 
obvious lesions present on the line of scarification.
By 14 weeks the plaques had a roughened surface and the 
scarification line was now confluent with these lesions. 
Histologically the epithelium was thickened in places due to 
keratinocyte proliferation and there was the beginning of the 
formation of plexiform acanthosis. There were no obvious 
cytopathic cells and there was no viral antigen detected by 
the PAP technique, using type specific antisera. Again no 
lesions were seen on any of the vaccinated animals.
When biopsied at 20 weeks the lesions on the unvaccinated 
calves were circumscribed with a filliform surface. 
Microscopically the lesions were true epithelial papillomas 
of specific type. The stratum granulosum was thickened, 
especially in the areas between the papillomatous 
projections. In the upper keratinocyte layer there were many 
virus containing nuclei when examined by H & E and this 
finding was confirmed by the PAP technique.
Two of the vaccinated calves were not however free from 
lesions at this examination. On the line of scarification in 
calves 101 and 105 there were small but prominent, depilated 
lesions which did not resemble the BPV-6 tumours induced in 
the unvaccinated calves and were obviously fibropapillomas. 
This was confirmed by histological examination as a typical 
cutaneous fibropapilloma and viral antigen was positively 
demonstrated by the PAP technique, using a cross-reactive 
antisera.
In the unvaccinated calves at 26 weeks there appeared to be 
a secondary spread of these tumours. Histologically the 
tumours appeared as before except there was more fronds, some 
of which were hyperkeratotic. There was a dramatic increase 
in the number of cytopathic cells and in the appearance of
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masses of irregular keratohyalin granules. Virus containing 
cells were easily found by the PAP technique, using type 
specific antisera.
In the vaccinated group 103 still had no lesions but the 
fibropapillomas on calves 101 and 105 continued to develop. 
When examined by H & E they were fully developed, 
hyperkeratotic fibropapillomas with marked plexiform 
acanthosis. There was an abundance of cytopathic cells which 
were immunologically positive by immunocytochemistry (PAP).
At 31 weeks the biopsy appeared similar to the previous 
except the lesion was completely hyperkeratotic. There was an 
chronic inflammatory reaction in the sub-epidermal tissue and 
in several areas there was interruption of the epidermo- 
dermal junctions. Cytopathic cells were still evident at this 
stage.
The fibropapillomas on the vaccinated group had to be 
surgically removed due to the marked increase in size of the 
lesion and also because it was ulcerating. There was still 
an abundance of viral antigen in the upper granular layer 
when examined by the PAP technique. This was confirmed by 
restriction mapping and hybridization as a BFV-1 infection.
Discussion
The rationale of using bovine cells transformed in vitro as a 
protective agent was that the protein products of the 
'early' genes, involved in transformation, could be present 
on the surface of the cells and be effective in immunising 
against tumour induction by BPV-2.
Experiment 6 was designed to test this theory. However, 7
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weeks after the application of the viral challenge 
preparation, a Stage 1 fibropapilloma developed on both the 
vaccinated and non-vaccinated calves. At week 8 they had 
developed into Stage 2 tumours and by the 11th week the 
lesions were fully developed Stage 3 fibropapillomas with 
viral containing cells present. For over 6 months these 
fibropapillomas were virally active but at week 35, although 
there was still a confluent line of typical fibropapillomas, 
there was no viral antigen to be detected by 
immunocytochemistry. The lesions finally sloughed off after 
40 weeks had elapsed.
The attempts to protect by immunising against infection by 
BPV-2 using in vitro transformed bovine fibroblast cells was 
not successful. This may be due to a low level of the 
appropriate antigen.
The next experiment was designed to test and compare the 
efficacy of a BPV-2 tumour suspension and purified virions, 
to induce rejection of a papillomavirus infection.
Before this experiment was done, it was unknown whether 
protection depended on structural antigens of the virus, 
early antigens in the viral replicative cycle or neo-antigens 
of tumours. The experiment was therefore structured to make 
an exact comparison by taking 2 aliquots of tumour, making a 
homogenate of one and a virus purification from the other. 
The second preparation should only contain structural virion 
antigens while the first contained all three.
Tumour development was first recorded in the unvaccinated 
calves 4 weeks after application of the viral challenge 
preparation. By the 9th week all the unvaccinated calves had 
prominent fibropapillomas with cells containing viral 
antigen. There was also at this stage one animal from each of 
the virus vaccine group and the tumour vaccine group, which
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had a small fibromatous nodule present on the line of
scarification. Histologically, these lesions showed no 
thickening of the squamous epithelium or any cytopathology 
and when examined by the PAP technique, there was no viral 
antigen detected. At week 14 there was no visible lesion seen 
on calf 70 from the virus vaccine group but in the tumour 
vaccine group, calf 65 had a Stage 1 fibropapilloma with an 
overlying ulcerated epithelium. All the other vaccinated 
calves were still free of a papillomavirus infection. The 
unvaccinated animals had well developed fibropapillomas with 
numerous cells containing viral antigen. Calf 65 from the 
tumour vaccine group did develop a Stage 2 fibropapilloma by 
week 18, with no virus containing cells but this lesion
suddenly regressed until week 29, when there was no visible 
lesion to be seen at the previous site of tumour development.
This experiment has demonstrated that animals could be
immunised against a homologous infection and oncogenesis by 
vaccines prepared from virus and tumour extracts. In the 
final assessment there was no difference between the two 
preparations. The common feature of both vaccines was the 
presence of virus and their structural proteins.
With the success of therapeutic regimes in protecting against 
a member of Group A virus, it was logical to examine the
efficacy of a therapeutic vaccine preparation from Group B.
The first experiment in this group was using purified BPV-4 
virions as the immunogen. The first mouth examination at 4 
weeks revealed that there were numerous, small projectile 
lesions on the palate of the unvaccinated calves. Although 
the lesions were small, they contained several cells with 
viral antigen in the sub-keratin layer of the incorporation 
areas. The vaccinated animals had no visible lesions. All the 
calves were subsequently subjected fortnightly, over a six 
month period, to a clinical examination and the appropriate
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biopsies taken. In the unvaccinated animals, the projecting 
lesions developed into true epithelial papillomas by week 8. 
The lesions were typical of a BPV-4 infection and the upper 
keratinocyte layer showed the presence of virus containing 
nuclei, which were immunologically positive by the PAP 
technique. No lesions were observed at any time in the mouth 
of the immunised animals.
Again this experiment demonstrated that cattle can be 
protected against a homologous infection and oncogenesis by 
parenteral inoculation of purified virus.
Finally, it was decided to examine a prophylactic vaccine 
regime using BPV-6 as the immunogen. BPV-6 tumours are the 
most common of the paragenital lesions and present themselves 
as a serious clinical and economic problem.
The first lesions were observed at 10 weeks after the 
challenge, on the unvaccinated animals. These were plaque­
like lesions on the site of scarification application but no 
lesions were visible on the vaccinated animals. By week 20 
these plaque lesions had developed into typical frond-like 
BPV-6 tumours. In the upper keratinocyte layer there were 
many virus containing cells. Again no BPV-6 induced lesions 
were seen on the vaccinated calves but there were small, 
depilated lesions lesions which did not resemble a BPV-6 
infection on two of the calves. These were morphologically 
fibropapillomas of a quite different structure than the BPV-6 
lesions and they contained large amounts of BPV-1.
In chapter 2 the development and timing of the various 
papillomatous lesions was discussed in detail. However in 
this particular experiment and subsequent studies, which will 
not be dealt with in this thesis, it was found that the 
latency period of this BPV-6 infection was much longer than
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that for BPV-2 and -4; in this instance full development was 
not completed until four months after challenge. It was also 
noticeable, in contra-distinction to BPV-2 and -4, that 
secondary spread of tumours from the infecting site to 
surrounding skin took place.
Virus for this experiment had to be obtained from naturally 
occurring tumours of the udders of cattle from commercial 
farms. Co-infection of the teat with individual discrete BPV- 
1 and -6 tumours occurs in 23% of cattle cases (Lindholm et 
al, 1984) . Large numbers of cases were examined in an attempt 
to obtain teats showing only BPV-6 frond-type papillomas for 
virus purification. Examination of the purified virus 
preparation by Southern blot hybridization technique, using 
cloned DNA probes of all the BPV types showed only the 
signals for BPV-6. This is a very sensitive technique. 
However, in this experiment a BPV-1 fibropapilloma arose.
Two possibilities had to be examined; one, the more obvious, 
is that the challenge material was contaminated by skin 
containing small amounts of BPV-1 virus or viral DNA. The 
small amount would be reflected in the long latent period 
before the tumours were recognised. The second possibility 
was that the recipient animals had latent non-clinical BPV-1 
infections. This has been shown to occur in a variety of 
circumstances (Jarrett, 1987). There is at present no 
knowledge of whether the development of overt tumours of one 
type can lead to the activation of latent virus of another 
type. This phenomena has not been seen at other BPV infection 
sites other than on the teats.
This experiment has shown that BPV-6 induces immunity to 
reinfection against homologous virus, but it does not protect 
against a BPV-1 infection.
In chapter 4 it was shown that papillomavirus infection with
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tumour induction and regression leads to only type-specific 
immunity. This also stands true for vaccination against BFV- 
2, 4 & 6 infection by intra-muscular injection of virus and
adjuvant.
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CHAPTER 6
FINAL CONCLUSIONS
The studies described in the preceding chapters of this 
thesis have resulted in the reproduction of papillomavirus 
infections in cattle. This was crucial in order to widen our 
understanding of the pathogenesis of the infection and to 
attempt to fulfill the objectives of this research project.
The methodology, which was developed for purifying
papillomaviruses, for both transmission and immunisation 
studies appeared satisfactory for the aims of this study. The 
immunocytochemical techniques used for the demonstration of 
BPV antigens was found to be sensitive enough to locate 
precisely the viral distribution and its relationship to the 
development of the lesion.
The final conclusions of this thesis can be summarised as 
follows;
1) Following the isolation of different BPV types and 
their classification by DNA restriction and 
hybridization, immunocytochemical techniques were 
developed to identify each of the viruses.
2) This peroxidase anti-peroxidase method demonstrated 
that each virus had specific lesion types and life 
cycle as had been inferred from morphological and 
molecular biological studies of spontaneous field cases 
of the different tumours.
3) The pathogenesis study revealed the nature and timing 
of virus replication and shedding for a range of virus 
infections.
4) Immunity to reinfection was produced by the tumour 
induction and regression cycle. It appeared to be 
strictly type-specific as judged by BPV-2, 4, 5 and 6 
cases.
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5) Prophylactic vaccination was possible by the 
intramuscular injection of purified virus only. This 
demonstrated that protection is specified by virus 
structural proteins and not 'early' virus gene 
expression. No obvious advantage was seen in 
administering the virus along with a suspension of 
papilloma cells. Immunity to reinfection was not 
produced by injection of bovine fibroblasts 
transformed in vitro by BPV-2 and expressing only 
products of the 'early' genes.
6) This work paved the way to choosing genetically- 
engineered products of the structural genes, LI and L2, 
which form the capsomeres of the virus. It was then 
found that the product of the LI, but not the L2, 
conferred immunity to reinfection of the same nature 
described here for purified virus.
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